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ABSTR A C T
In this study the use of a He-Ne laser as excitation 
source in fluorescent endoscopy is investigated 
Fluorescence endoscopy is based on the principle of 
injecting a fluorescent tumour localiser prior to 
examination with a fibre-optic endoscope Tumours marked 
by the fluorescent localiser can then be identified by the 
detection of the characteristic fluorescence output of the 
localiser The localiser examined m  this research is 
Haematoporphyrin or Hp
Previous studies with Hp have generally utilised the 
violet portion of the visible spectrum (400nm) to excite 
fluorescence Spectroscopic studies carried out in this 
project reveal that He-Ne laser light (632 8nm) can be 
used to excite Hp fluorescence It is shown that 632nm 
excitation possesses significant advantages over the use 
of violet light for the detection of small tumours deeply 
embedded in healthy tissue
One such type of tumour is early small cell carcinoma 
of the tracheo-bronchial (TB) tract These tumours may 
only be a few millimetres in extent and up to 0 5mm thick 
Such a small tumour will have very small amounts of the Hp 
marker material This combined with the fact that Hp has a 
very low excitation efficiency at 630nm will result in a 
very low fluorescent emission To detect such a low level 
light signal a highly efficient illumination and detection 
system is required Such a system has been developed and 
is described in chapter 3 In vitro experimentation 
demonstrates that the system can detect fluorescence from 
concentrations of Hp down to as low as 0 01 pg/ml in 
methanol and 0 1 /¿g/ml in water
A comprehensive mathematical model has been developed 
to predict the response of the detection system for the 
detection of early small cell^TB tumours The model 
predicts that the instrument can detect tumours as low as 
2 5mm in extent and 0 3mm thick embedded deep within the 
submucosa of the TB tract
In order to measure the response of the instrument in 
conditions which simulate a clinical environment a 
tumour-tissue phantom has been developed Experiments 
carried out on the phantom with the endoscopic apparatus 
yield results in very good agreement with those predicted 
by the model
In conclusion it has been shown that He-Ne laser 
light can be used as an effective excitation source in 
fluorescent endoscopy for the detection of previously 
undetectable tumours The use of He-Ne laser excitation in 
fluorescent endoscopy could then play a role in the cancer 
screening of high risk sections of the population
Chapter 1
LITERATURE REVIEW
1 1 Introduction
Photomedicine has been defined as the  use o f  l i g h t  in  
m e d i c a l l y  r e l a t e d  a c t i v i t i e s  in c l u d i n g  the  p r e v e n t i o n  o f  
d i s e a s e , t h e  p r e p a r a t i o n  o f  p h a r m a c e u t i c a l s , th e  d ia g n o s i s  
and t r e a tm e n t  o f  d i s e a s e ,  and the  e l u c i d a t i o n  and e t i o l o g y  
o f  d i s e a s e (1) In recent years research activity has 
expanded both in terms of fundamental research and in the 
clinical applications of photomedicine Modern applications 
of photomedicine can be divided into two categories
(i) where light is utilised alone e g the surgical 
application of lasers and the treatment of 
jaundice in premature babies by means of their 
exposure to ultra-violet light ,
(ii) where light is used in conjunction with a 
previously administered light sensitive dye
IIn the latter case the use of tumour-seeking agents 
such as Haematoporphyrin Derivative (HpD) have been used in 
combination with light to localise as well as treat cancer 
tumours The basic principles of this technique are 
outlined in Fig 1.1 (2). HpD in low concentration is
injected intravenously It spreads quickly through the 
body 2-3 days later it is observed to selectively
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accumulate in tumour tissue while being removed from 
healthy tissue by natural processes The mechanisms for 
this retention are still unclear
Light irradiation of the tumour bound HpD, with ^
wavelengths corresponding to one of its excitation peaks, 
will result in the emission of a characteristic red
fluorescence The detection of this HpD fluorescence above
background serves to identify the location of the tumour 
If enough light energy is supplied to the tumour, light 
induced chemical changes triggered by the HpD molecules can 
occur causing eventual tumour destruction This cancer 
treatment is known as Photodynamic therapy (PDT) Thus a 
combination of light and HpD may be used in both the 
diagnosis and treatment of cancers
It is the aim of this project to design and test an 
effective system for the detection of fluorescence from a 
HpD marked tumour Firstly a review of the early
development of photomedicine is presented It is shown how 
this leads to the discovery of photosensitisers and
ultimately to the utilisation of the fluorescent and 
localising properties of HpD for the detection of tumourous 
areas. Subsequently recent clinical techniques for the
N
detection of cancers using HpD are reported It is in the 
light of these techniques that a system is designed and 
tested for the detection of HpD fluorescence (see chapter
3)
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Fig 1.1 Schematic diagram of cancer detection using HpD in 
combination with laser irradiation (2)
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Although evidence exists that the ancient Chinese and 
Egyptians (1) were aware of the medical properties of 
light, modern studies began only about 100 years ago when 
the Danish scientist Niels Finsen successfully treated the 
tubercular skin lesion known as lupus vulgaris This 
disease manifests itself by the protrusion of darkly 
coloured lesions on the surface of the skin and was 
endemic among Scandinavians during the dark winter months 
Finsen proposed that the disease was caused by 
underexposure to ultra-violet (u v) light from the sun By 
exposing a lesion to irradiation from a u v source he was 
able to trigger intrinsic chemical reactions which 
destroyed the lesion The process by which this occurred 
was then a mystery, but the disease was observed to clear 
up and within 10 years of Finsen commencing his treatments 
had all but disappeared in Scandinavian countries By 
this technique Finsen had established the principle that 
light could be used in medicine By the turn of the 
century photomedical techniques were being tested in the 
Finsen Institute m  Copenhagen, and in the London 
Hospital Finsen received the Nobel Prize for Medicine in 
1903 and the science of photomedicine was born (3)
At around the same time Oscar Raab, a medical student 
in Munich, found that low concentrations of acridine and 
other dyes demonstrated a rapid killing of small 
multicellular organisms such as protozoa and paramecium
1 2 Historical Background
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upon illumination (4) During the course of the next few 
years his professor, Hermann Von Tappeiner, conducted a 
series of experiments on biological tissues He found that 
upon light irradiation cellular damage could be affected in 
the presence of a wide variety of dyes The photochemical 
reactions which caused cell death and necrosis only 
occurred when the tissue was irradiated with wavelengths of 
light corresponding to the absorption peaks of the dye 
When Von Tappeiner published his results in 1903 (5) he 
suggested the combined use of light and eosin as a 
treatment for a number of skin diseases ranging from skin 
cancer to herpes Von Tappeiner and Raab had discovered the 
existence of photosensitive dyes which were normally 
inactive but could be photo-activated to induce chemical 
reactions which could destroy tissue This added an extra 
dimension to photomedicine as it suggested the possibility 
of being able to selectively destroy tumourous areas while 
leaving the surrounding tissue unharmed The therapeutic 
prospects of such a discovery1seemed very bright indeed
1 3  In Search of the Ideal Photosensitiser
The use of photosensitive dyes in medicine appeared 
very promising but early medical applications were to 
prove disappointing Clinical trials by von Tappeiner and 
Jesionek were a limited success (6) Skin tumours in 3 
patients were treated using a topically applied eosin 
solution as photosensitiser. All 3 patients showed some 
improvement. Other dyes such as fluorescein, acridine 
orange and magdaline red were also used with similar but
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with inconclusive results (6) In 1925 Copeman et al (7) 
attempted to treat skin tumours by painting fluorescein 
solutions onto the affected areas and illuminating these 
areas with light from a Mercury arc lamp He reported no
■J
favourable results These drawbacks served to dampen early 
enthusiasm for photosensitisation The momentum was 
regained in 1942 when Auler, Banzer and Figge focussed
their attention on the photosensitising properties of a 
group of chemical compounds known as the porphyrins (8)
The photosensitising properties of porphyrins were
first demonstrated in 1913 Meyer Betz, an Austrian 
chemist, injected himself with 200 mg of Haematoporphyrin 
(Hp) and observed that in the presence of light the exposed 
parts of his body became red and swollen The effect lasted 
for several weeks post injection (3) Auler et al (8) 
inj ected laboratory animals with a porphyrin solution and 
upon illumination they detected red fluorescence from 
surface tumours After the war, Figge continued his 
research and showed that Hp was the most effective
porphyrin for the localisation of a wide variety of cancer
types (9)
In 1961 Lipson and Baldes (10) pointed out that the 
fluorescent yield and the localising capability of Hp in 
tumours, were variable This was attributed to the varying 
composition of the Hp mixture which they were using 
Subsequently they standardised the preparation of Hp into a 
Haematoporphyrin Derivative (HpD) (11). HpD has been shown 
to be a complex mixture of various porphyrins and a full 
description of its preparation and constituents is outlined
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in chapter 2 Lipson and Baldes (10) outlined the 
advantages of using HpD as follows
(1) Greater localisation in malignant cells.
(2) Less accumulation in healthy tissue
(3) Greater consistency and reproducibility in results
The excitation and fluorescent spectra of HpD are almost 
identical to that of Hp, although HpD has a slightly lower 
fluorescence yield
By the use of HpD and a sufficiently intense 
ultra-violet illumination source, Lipson and Baldes were 
able to observe good localised fluorescence for a number 
of tumour types The results were significantly better 
than those using crude Hp Clinical trials followed and by 
1967 Lipson was able to report a 95% detection rate for 
malignant tumours in humans (12) Since then HpD and 
commercial variants has been the main photosensitiser in 
clinical use for the detection of tumours (27)
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1 4 Instrumentation and Methods in Tumour Detection
Tumour detection using HpD relies on two main 
properties of porphyrins namely their high fluorescent 
quantum yield and their localising ability Throughout the 
years numerous clinical techniques have been developed to 
exploit the use of HpD in cancer diagnosis Recently with 
advances in endoscopic technology interest has increased 
in the use of HpD for the early detection of thin 
superficial tumours in the bronchial and gastro-intestinal 
tracts This field of interest has been termed 
"fluorescence endoscopy" In this section several 
techniques of cancer diagnosis using fluorescence endoscopy 
are discussed Any apparatus must include both a system 
for the conduction of excitation light to the porphyrin 
bound in the tumour and a system for the collection and 
detection of the resultant fluorescence In order to 
simplify the discussion methods of fluorescence endoscopy 
are reviewed in terms of whether an arc-lamp or a laser 
are used as excitation source
1 4  1 Arc Lamp Systems
Before the invention of the laser, arc-lamps were the 
light sources of choice in photomedicine Finsen (3) had 
used a carbon arc-lamp for treating lupus vulgaris and 
Raab and and Von Tappeiner (4) (5) had used Mercury (Hg) 
arc-lamps m  their studies Similarly many researchers 
have used arc-lamps as the excitation source in 
fluorescence endoscopy
In 1979 Profio and Doiron (13) outlined the use of a
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200 W Hg arc lamp with a fluorescent bronchoscope for the 
detection of tracheo-bronchial (TB) tumours An advantage 
of using a Hg-lamp was that use could be made of the strong 
Hg line at 404 7nm , which corresponds to the major 
excitation peak of HpD In fig 1 2 the system of Profio and 
Doiron is illustrated
The lamp is focussed on a narrow bandpass violet 
filter centred at 405nm, in order to remove any unwanted 
Hg emission The resultant violet light is refocused onto 
a specially made bundle of quartz-glass which has 
enhanced ultra-violet transmission This bundle carries 
the 405nm excitation light to the tumour site where the 
HpD bound to the tumour fluoresces in a broad red region 
of the spectrum from approximately 630nm to 690nm The 
fluorescent light is then focussed by means of a lens onto 
an imaging bundle At the proximal end of this bundle the 
light is passed through a red filter, in order to reject 
any reflected violet light which may have travelled down 
the imaging bundle The remaining "pure" fluorescence 
image is incident on the photocathode of an image 
intensifier and the fluorescent image from the intensifier 
is viewed directly Alternately, the fluorescent signal 
can be passed to an appropriate photodetector and 
amplifier and the fluorescent signal measured digitally 
The authors reported the detection of TB tumours in 3 of 4 
patients previously known to have cancer. In a later 
publication (14), however, they conceded that the tumours 
detected were also visible by x-ray and conventional 
white-light bronchoscopy
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The m a m  disadvantage in the use of ultra-violet 
excitation light is the presence of a large healthy tissue 
auto-fluorescent signal which tends to mask the 
characteristic HpD fluorescence from the tumour The 
phenomenon of auto-fluorescence is caused by the 
excitation of intrinsic chromophores present m  healthy 
tissue and gives rise to many false diagnoses The 
auto-fluorescence spectrum of HpD is contained in fig 1 1 
Maximum auto-fluorescence emission is obtained for 
excitation at violet wavelengths (i e 400-450nm) In 
order for tumour detection to occur the HpD fluorescence 
must be detected above the auto-fluorescent signal
In 1986, Mattiello and Hetzel (15), described a 
similar system using a Hg-Xe lamp, and a bi-furcated fibre 
bundle. This bundle consisted of a quartz excitation fibre 
designed to transmit only light around 405nm, and a glass 
bundle constructed to transmit only 630nm fluorescence 
Excitation light is passed down the fibre to the tumour 
and the fluorescent signal was detected using a narrow 
bandpass red filter and a photomultiplier tube (PMT) 
situated at the end of the fluorescent bundle A chopper 
is used to alternately switch off the excitation signal 
while the white light of an illumination guide is 
transmitted to enable the clinician to observe the area 
under treatment in a normal fashion The voltage signal 
from the PMT is converted to frequency and used to produce 
an audio signal for the clinician
The use of a chopper in this set-up allows for the
detection to occur in phase with the excitation signal, 
and thus reduces the level of background noise detected
The papers reviewed above indicate that arc-lamps can 
be used in fluorescence endoscopy However several 
disadvantages inherent in the use of arc-lamps have become 
evident These disadvantages are outlined below *
1 Heavy filtering is required to select the correct
wavelength and reduce the auto-fluorescent signal 
from the tissue
2 The low light intensities obtained 
from arc-lamps at the desired wavelength
necessitate the use of high wattage lamps 
These lamps prove expensive and the high
voltages required often interfere with the 
detection electronics
3 It is difficult to couple arc-lamp light into 
single fibres. For this reason thick
fibre-bundles are required to convey the
excitation light This limits the locations 
within the body which the arc-lamp can access
In 1987, however, Anderson et al (16), described a
technique which used a Hg arc lamp and avoided some of the
disadvantages mentioned above Their method used a standard 
endoscope and involved the use of a Hg lamp to supply both
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the excitation (405nm) light and the white light required 
for normal illumination. As in the case of Mattiello et al 
they used an optical chopper to alternately switch on the 
white light illumination while switching off the excitation 
light and the photodetector. In their chopper (see Fig 1.3) 
they incorporated a green and a red filter which allowed 
the detection of both the HpD fluorescence(red) and the 
normal tissue fluorescence (auto-fluorescence, green). This 
red:green ratio, when gathered electronically, was the 
basis for their tumour detection. Furthermore, by 
extrapolating the normal tissue fluorescence to the red 
region of the spectrum a value for the tissue 
auto- fluorescence, at the HpD fluorescent wavelengths was 
obtained. This value was subtracted electronically from the 
detected signal to give a true value for the fluorescent 
signal.
In this method tumour fluorescence was detected using 
a standard clinical endoscope. Its filtered chopper and 
ratio method of fluorescence detection reduced the problems 
due to auto-fluorescence and incorporated the advantages of 
Mattiello's system.
In 1988 Lenz (17) introduced a new concept when he 
described an endoscopic system whereby a chopper was used 
to alternately detect fluorescent signal (F) and reflected 
excitation light (R), from a Xenon arc lamp. The ratio F:R 
is then used as a measure of tumour detection. The authors 
claimed that this technique has the effect of reducing the 
effect of parameters such as distance of fibre bundle from 
the tumour, the power of the source, and any temporal
12
variations which may influence the system
The techniques mentioned in this section have 
increasingly maximised the efficiency of using arc lamps as 
excitation sources by removing the disadvantages of 
background signal and tissue auto-fluorescence as 
effectively as possible Despite this other disadvantages 
remain, the most serious of which is the poor coupling 
efficiency into single fibres In practice arc lamps are 
still in use The reason for this is that they are simple, 
relatively inexpensive, reliable, and, in the case of most 
research institutions and hospitals , readily available
If fluorescence endoscopy is to establish itself as a 
valuable method of cancer diagnosis, its success must lie 
in the early detection of small cancers otherwise 
undetectable to conventional cancer diagnostic techniques 
It was for this reason that attention was focussed on the 
laser. Lasers have a very good coupling efficiency into 
single fibres facilitating the use of more flexible 
endoscopes which can access more remote tumour sites 
Similarly they are monochromatic with intense emission at a 
single wavelength In the following section several 
techniques of fluorescence endoscopy using lasers are 
assessed
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1 4  2 Laser Systems
Most of the techniques described in the arc-lamp 
section can be performed, with slight modifications, using 
a laser source The most commonly used laser is the CW 
Krypton ion laser which typically has a power output of 
circa 1 watt and can lase at 407nm (close to the main
absorption peak of HpD) Other lasers that have been used 
are the argon-ion laser and several pumped dye lasers The 
reasons why lasers are not more widely used is that they 
are not always readily available and that they are 
relatively expensive with a Krypton ion laser costing circa 
$60-120,000
It was Profio and Doiron (1979) (18) who first
proposed the use of a Krypton ion laser as excitation 
source They used a system similar to their earlier
apparatus in which a Hg arc lamp was used. The main
difference was that with the laser they could now use a 
single excitation fibre Consequently, the light intensity 
at the distal end of the fibre was higher and the entire 
system was more flexible, and capable of detecting more 
remote tumours Cortese and Kinsey (1979) (19) also
described a similar endoscopic apparatus utilising a 
Krypton ion laser Clinical trials, however, showed that 
the potential of fluorescence endoscopy was limited by the 
large number of erroneous results obtained These errors 
could be classified as follows
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(1) False Positive results caused by the violet light 
excitation of intrinsic tissue chromophores 
i e tissue autofluorescence
(2) False Negative results caused by tumours located 
under epithelial layers thick enough to absorb 
all of the excitation light
In order to alleviate these problems Zandomeneghi et 
al (20) suggested the use of He-Ne lasers for the 
excitation of the tumour bound HpD He-Ne lasers are cheap, 
reliable and easy to maintain and install They emit at 
632 8nm, which corresponds to one of the minor absorption 
peaks of HpD
Zandomeneghi et al reported the use of an instrument 
for the detection of HpD fluorescence from large tumours 
grown on the legs of laboratory mice. A lOmW He-Ne laser 
was used as excitation source and the resultant 
fluorescence passed through an infra-red filter and
detected on photographic film In this way fluorescence
images of the tumour site were obtained The photographic
plates were then scanned using a micro-densitometer and 
fluorescent readings from both tumour bearing and normal 
animals recorded. A ratio of these values was then 
obtained. By using this ratio problems due to residual
noise and background auto-fluorescence were reduced 
Although they used a large experimental tumour the authors  ^
claimed the advantages of using red light were significant 
and suggested the He-Ne laser as the ideal excitation 
source for use in fluorescence endoscopy
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The discovery of the fluorescent and localising 
properties of Hp followed by its standardisation into HpD 
has prompted much research into its exploitation for the 
early detection of tumourous areas. In the field of 
fluorescence endoscopy the poor coupling efficiency of 
arc-lamps into single fibres seems to severely limit the 
locations in which tumour detection can occur. Laser light 
however can be coupled down single fibres and access remote 
areas in the tracheo-bronchial (TB) and gastro-intestinal 
(GI) apparatus. From the literature however the use of 
Krypton-ion lasers have been shown to result in large 
numbers of false diagnoses. The use of red He-Ne laser 
light, as proposed by Zandomeneghi (20), seems to offer a 
more attractive proposition than the use of violet Krypton 
laser light for the following reasons
(1) red light has good penetration in tissue 
(significantly better than blue light 
penetration)
(2) red light penetration is not affected by the 
presence of blood while blue light is 
strongly absorbed by Hemoglobin
(3) autofluoresence at 630nm is negligible 
compared to levels recorded at blue 
wavelengths.
(4) 630run is the wavelength used for therapy 
purposes via PDT.
1.5 Conclusion
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The problem with using a He-Ne laser is that power 
outputs are low and its emission at 630nm corresponds to a 
minor absorption peak of HpD For this reason any system 
using a He-Ne laser as source must incorporate a detection 
system capable of detecting very small fluorescent 
signals
Recently the use of ratio methods of fluorescent 
detection have been outlined (16,20) These methods present 
an advantage over straight fluorescence detection in that 
they are claimed to reduce the effect of extraneous factors 
on the detection process This is a particular advantage 
when dealing with tumour fluorescence detection
In the light of the techniques reviewed in this 
chapter an instrument is developed in chapter 3 which 
investigates the use of a He-Ne laser for excitation and a 
ratio method for the detection of Hp fluorescence The 
sensitivity of this system is tested and its adaptability 
for the detection of human tumours via fluorescence 
endoscopy assessed
18
Chapter 2
HAEMATOPORPHYRIN
2 1 Introduction
A photosensitiser can be defined as a chemical  
compound which i s  n orm al ly  s t a b l e  and i n e r t  bu t  upon 
photo  s t i m u l â t ion i n i t i a t e s  chemical  changes in  o th e r  
compounds m  i t s  environment (24) In this chapter the 
photosensitising dye Haematoporphyrin (Hp) is discussed 
Together with its photosensitising properties 
Haematoporphyrin has been noted to selectively accumulate 
in tumourous tissue (see chapter 1) This property is known 
as localisation Haematoporphyrin's twin properties of 
photosensitisation and localisation have been used in 
medicine to both detect and treat cancer tumours In this 
chapter the photosensitising and localising properties of 
Haematoporphyrin are described and the mechanisms by which 
Hp is used to both detect and treat tumours are outlined
Work is then presented on the examination of the 
excitation and emission spectra of Hp This work was 
carried out using a spectrofluorimeter and on solutions of 
Hp in an aqueous environment These spectra serve to locate
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the excitation peaks of Hp and provide a comparison of the 
location and strength of fluorescent emission for each 
excitation peak The sensitivity limits i e the lowest 
detectable concentrations of Hp are then obtained for each 
of the excitation peaks This provides information on the 
feasibility of using red light over violet light as 
excitation source in fluorescence endoscopy
2 2 Porphyrins
The porphyrins are one of the oldest and most well 
documented of chemical families They are characterized by 
their bright colours and strong fluorescent properties (3) 
Their parent substance, porphin, is a purple crystalline 
solid, made up of four pyrole rings each containing four 
carbon atoms and one nitrogen atom linked to form a large 
ring (see fig 2 1) In the centre of the ring is a cavity 
surrounded by the four nitrogen atoms of the four rings 
This cavity can accommodate any one of a variety of metal 
ions The chemical properties of each porphyrin depend on 
the presence and type of metal present in the centre
Porphyrins are readily found in nature and play a 
vital role m  the process of living Iron porphyrins called 
haems are found in hemoglobin and myoglobin Protohaem, the 
porphyrin in hemoglobin is responsible for carrying oxygen 
to the tissues in mammals Chlorophylls, which play a role 
in photosynthesis in plant cells, are porphyrins with a 
magnesium ion in the core.
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Fig 2 1 The chemical structure of porphin
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Fig 2 2 The chemical structure of Haematoporphyrin
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2 3 Haematoporphyrin (Hp)
The first porphyrin to be synthesized artificially 
was Haematoporphyrin, when in 1867 J L Thudicum prepared 
it by treating Hemoglobin with sulfuric acid and following 
that with extraction with alcohol (21) Hp is 
characterized by the absence of a metal ion in its core 
and the presence of two hydroxyethyl groups, two propionic 
acid groups and four methyl groups attached to the four 
pyrole ring (see fig 2 2) Haematoporphyrin is not a 
naturally occurring compound and has not been isolated in 
nature Indeed a statement has been made in the literature 
(27) that a pure sample of Hp has never been produced
Since its discovery Hp has been extensively studied 
and analyzed (for a review see Kessel (22)) In medicine 
researchers became interested in Hp because of its 
properties of photosensitisation and localisation In 1960 
Lipson and Baldes suggested that these two properties could 
be exploited in tandem for the detection and treatment of 
cancer It was not until the early 1970s (Diamond 1972 
(23), Barenbaum et al 1975) that such a technique began to 
be used clinically In the following sections these two 
properties of localisation and photosensitisation are 
discussed in more detail.
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2.3.1 Localisation:
No adequate explanation has yet been brought forward 
to explain why porphyrins localise in tumorous tissue 
despite the fact that it has been observed since the
1940s. In 1942 Auler, Banzer and Figge (8) discovered that 
mouse tumours selectively retained Hp after its disposal 
by healthy tissue. In 1961 Lipson and Baldes (10) reported 
the selective retention of Hp in human cancer cells, 2-3
days after the porphyrin was injected into the blood
stream. This property of Hp localisation together with the
strong fluorescent properties of Hp made it possible to
locate previously undetectable tumours.
2.3.2 Photosensitisation
In order to understand how a photosensitiser works let 
us consider a system consisting of 2 chemical compounds X, 
Y. As this system does not contain a photosensitiser it 
does not exhibit any photochemical change when irradiated
with light of particular wavelengths. Thus :
hu
(X, Y ) —* (X, Y) (no reaction)
However when the photosensitiser (S) is present 
the photochemical reaction does occur as follows :
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hi?
(X, Y ) -*■ (X, P ) (sensitized reaction Y -+ P)
Hp's properties as a photosensitiser have been well 
known, ever since Mayer-Betz's famous 1913 experiment (25) 
(described in chapter 1) In this chapter the role of Hp as 
a photosensitising agent in biological tissue is 
emphasized
Most cells are rather insensitive to direct effects 
of visible light, (the exception being cells which contain 
melanin and other natural pigments), since their major 
organic constituents do not absorb appreciably in this 
wavelength range In the presence of an appropriate 
photosensitiser such as Hp, organisms, cells and many 
types of biologically important molecules can be damaged 
and destroyed by visible light (24)
In the case of Hp the photosensitised reaction 
results eventually in a change of the electronic energy of 
molecular oxygen (C>2) from its stable triplet state to a 
highly reactive singlet state This singlet state attacks 
fatty materials and cell membranes causing cell death If 
sufficient cells are killed tissue necrosis will occur In 
the next section these photosensitised reactions are 
discussed in more detail.
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2.4 The Role of Hp in the Detection and Treatment of Cancer 
In fig 1 1 the various stages involved in the 
detection and treatment of tumours using Haematoporphyrin 
are outlined After about 2 days post injection the Hp is 
seen to selectively accumulate at the tumour site while it 
has been removed from healthy tissue by natural processes 
If the tumour is then exposed to visible light the
presence of the photosensitiser will cause the following
two simultaneous reactions to occur .
(1) The emission of characteristic red Hp 
fluorescence
(2) The conversion of oxygen molecules within the
tumour from their stable triplet
state to the highly reactive singlet states
The mechanism by which these reactions occur is
outlined on the following pages
In order to study the mechanisms by which these
photosensitised reactions occur it is important to discuss 
the absorption spectra of Hp The major absorption of Hp 
occurs in the so called Soret band peaking at 405nm and 
corresponding to transitions from the ground singlet state 
to the second excited singlet state Further minor
excitation peaks at 500, 530, 570, and 630nm respectively 
correspond to transitions to the first excited singlet
state (see fig 2.3) Regardless of how the excitation was 
performed the molecules are non-radiatively transferred to 
the lowest vibrational level of the singlet state from
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where fluorescence occurs Hp exhibits a characteristic 
dual-peaked fluorescent light distribution in the red 
spectral region. The detection of this spectral 
finger-print serves to identify the location of the 
tumour
Alternatively the excited Hp molecules can transfer 
their acquired energy to oxygen molecules at the tumour 
site This transfer is mediated by the long-lived 
metastable triplet state to which radiationless 
transitions can occur. This triplet Hp state has an energy 
of greater than 94 kilo joules per mole above that of the 
ground state
Molecular oxygen requires a large energy outlay of 94 
kilo joules per mole to be excited from its very stable 
triplet ground state to highly reactive singlet oxygen 
Visible light has more than enough energy to bring about 
the triplet-singlet transition But oxygen is transparent 
and thus has no way of directly absorbing that energy 
Triplet-singlet transition can occur however in the 
presence of a photosensitiser such as Hp Triplet Hp 
molecules transfer their acquired energy to the oxygen 
molecules and return to the ground state This energy is 
j'ust enough to facilitate molecular oxygen triplet to 
singlet conversion Singlet molecular oxygen is a strong 
toxic agent and oxidizes the surrounding (tumour) tissue
Fig 2.3 Energy level diagrams and processes relevant to 
photosensitised reactions involving Hp in tissue (2).
Singlet 
excited 10 2 
oxygen
Triplet 
ground state 
of oxygen
Triplet 
excited 
state of 
porphyrin
Singlet 
ground state 
of porphyrin
/
Exciting radiation
Singlet excited 
state of 
porphyrin
Fig 2.4 An outline of how Hp combines with light radiation 
to produce fluorescence and singlet oxygen (3).
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Both the emission of characteristic Hp fluorescence 
and the production of singlet oxygen occur simultaneously 
in Hp marked tumours upon irradiation with light 
containing the correct wavelength components Jori (1987)
(53) has quoted a quantum yield of 0 63 for the production 
of singlet oxygen by Hp in an aqueous environment upon 
630nm excitation In this way both the localising and 
photosensitising properties of Hp can be exploited in 
order to detect and treat cancer tumours In fig 2 4 the 
mechanism (described above) by which visible light and Hp 
combine to produce fluorescence and singlet oxygen within 
tissue is schematically outlined
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2.5 Haematoporphyrin Derivative (HpD)
In the previous section it has been shown how 
Haematoporphyrin (Hp) can be used in conjunction with 
visible light for the location and destruction of tumour 
tissue. In clinical circumstances however the use of Hp is 
problematic for the following reasons :
(1) Hp is not a naturally occurring substance and a 
pure sample has proven difficult to extract. Doiron (27) 
has reported that a pure sample of Hp has never been made 
available. Furthermore it has been shown by Schwarz and 
co-workers (27) that commercial preparations of Hp are a 
crude mixture of many porphyrins This was confirmed by 
Bonnett (28) who examined samples of available Hp using 
high pressure liquid chromatography (HPLC), and found an 
average of 10% impurities in each sample. These results 
cause unacceptable variability in results and make Hp 
difficult to control in a clinical situation.
(2) Richelli and Grossweiner (29) reported that age, 
temperature and pH of solution cause variation in the 
photochemistry of Hp.
(3) It is difficult to dissolve Hp.
Irreproducibility of results in clinical use with Hp 
was indeed noted by Lipson and Baldes (11). Schwarz (27) 
attributed this to variations in the chemical composition 
of the Hp samples they were using. In order to evaluate 
whether a more refined technique based on the accumulation
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of an administered porphyrin m  a tumour could be utilised 
for cancer detection Lipson and Baldes prepared 
Haematoporphyrin Derivative (HpD)
HpD is prepared by treating Haematoporphyrin 
dihydrochloride with a solution of sulfuric acid and 
acetic acid The full preparation is described fully 
elsewhere i.e Doiron and Bonnett (27,28) HpD is also not 
a pure compound HPLC studies by Moan and Summer (30) have 
revealed that HpD is a mixture of many compounds with at 
least four major components which are named 2, 4A, 4B, and 
7 Component two is ascribed to free Hp while 7 is 
protoporphyrin and the two other components are thought to 
be a mixture of numerous porphyrins The results of one 
such HPLC study is outlined in fig 2 5
Fig 2 5 HPLC studies of the major constituents of HpD and 
their respective volumes (as reported by Moan and
Summer (30))
\
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HpD has been found to have a greater localising 
ability than Hp (Lipson (11)) Moan and Summer suggested 
this to be due to a complex formed between component 2 and 
component 7 The fluorescent quantum yields between Hp and 
HpD are comparable and the absorption spectra of HpD is red 
shifted 5-10nm due to increased dimerisation (Pottier et
al (31))
,HpD can be prepared relatively simply However 
extensive purification is required to obtain a relatively 
pure sample of the constituents with the highest tumour 
localising ability The standard preparation of HpD 
provides a compound reasonably free from impurities and 
with greater localising ability than Hp This is of great
I
benefit in clinical practice At present work is in 
progress to further purify the derivative, and Photofrin I 
and 1 Photofrin II are the commercially available 
purifications currently in widespread use (26) Photofrin 
II is the product which is currently used for clinical
Itrials
i
~>
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In order to locate the excitation peaks of Hp and 
compare and contrast fluorescence emission at each peak a 
spectroscopic analysis of a solution of Hp + was
undertaken In this way the magnitude of the excitation 
peaks and their relative efficiency for the excitation of 
fluorescence from a HpD marked tumour can be assessed In 
chapter 1 the use of red light instead of the conventional 
violet excitation was proposed The spectroscopic studies 
carried out in this section allow a comparison to be made 
of the use of red over violet wavelengths for the 
stimulation of Hp fluorescence
Although HpD and its commercial purifications (i e 
Photofrin II) are used in clinical procedures it was 
decided to carry out these tests with Hp The reason for 
this is that the cost of Photofrin II is prohibitive and 
laboratory procedures for the extraction of 
Haematoporphyrin derivative (HpD) from Hp are quite 
complex As the photo physical properties of Hp and HpD are 
similar it was considered that Hp could be used as a 
convenient model for the clinically utilised HpD
2 6.1 Procedure
Emission and excitation spectra were measured with a 
Perkin Elmer MPF 44B spectrofluorimeter This system 
utilises a Xenon arc lamp as excitation source and a
2 6 Experimental Studies
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Hamamatsu R928 photomultiplier tube for detection The 
monochromator slits were set at a width of 4 5mm for 
maximum signal. All of the spectra obtained were corrected 
for the wavelength response of the spectrofluorimeter 
This had been determined previously by van der Putten
(54)
In section 2 5 it has been pointed out that the photo 
physical properties of Hp can be affected by factors such 
as pH, age and temperature. Similarly due to impurities, 
the chemical composition of one Hp solution may differ 
markedly from another causing a change in spectroscopic 
characteristics In order to obtain as great a degree of 
reproducibility of results as possible, a standard 
preparation of Hp solutions was developed Samples of 
anhydrous Hp were taken from a single vial. The Hp was 
weighed on a sensitive balance and added to 30 ml 
solutions of distilled water These solutions were 
refrigerated for 24 hours in order to preserve the samples 
while the dissolution process continued The resultant 
samples were placed in the spectrophotometer and 
excitation spectra obtained Fluorescent emission spectra 
were obtained for each of the excitation peaks The 
concentration of Hp in solution was progressively diluted 
in order to obtain the lowest concentration of Hp for 
which fluorescence could be detected for each of the 
excitation peaks. None of the Hp samples were kept for 
longer than 36 hours in total 1
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2.6.2 Results
The literature (31) suggests that the m a m  Hp 
fluorescence band is centred at 675nm. With the emission 
monochromator of the spectrophotometer centred at 675nm 
the excitation spectrum of Hp + was obtained by
scanning the excitation wavelength from 400 to 640nm and 
monitoring the fluorescent output at 675nm. This spectrum 
is shown in fig 2.6.
*
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The spectrum reveals the presence of five excitation 
bands centred at 410, 515, 555, 565 and 625nm respectively 
If the peak height of the 410nm band is taken as 100 then 
the relative magnitudes can be expressed as 100 4 4 6
4 8 1 8  In chapter 1 the use of He-Ne laser light to
excite fluorescence from a HpD marked tumour was proposed 
From fig 2 6 it is apparent that excitation of Hp can occur 
at 632nm (the lasing line of the He-Ne laser) but is much 
less efficient in comparison to the excitation obtainable 
at the commonly used 405nm
Using the same spectrophotometer the fluorescent 
spectra of Hp + H20 were obtained for excitation at 410, 
515, 555, 565 and 632nm respectively In this way the
fluorescent peaks of the Hp solution are located 
Comparison of the emission characteristics at these 
wavelengths provides information on the type of excitation 
sources which can be used in fluorescence endoscopy In 
chapter 1 the use of He-Ne laser light (632nm), instead of 
the commonly used Kr-ion laser light (410nm), as excitation 
source in fluorescent endoscopy is proposed Emission 
spectra for 410 and 632nm excitation were obtained in order 
to compare the fluorescent emission obtained at these two 
wavelengths The emission spectra for each of the five 
excitation wavelengths were obtained for increasingly 
dilute solutions of Hp + H20 The sensitivity limit i e the
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lowest concentration of Hp for which fluorescence can be 
detected were found for each excitation wavelength
In fig 2 7 fluorescent spectrum obtained by exciting 
a solution of l/*g Hp per ml of H^, with 410nm light is 
shown It displays a three peak spectrum, with peaks at 
585, 615 and 679nm These peaks are well documented (see 
Andreoni) (26) As the concentration of Hp in solution is 
reduced it was noticed that the 585 peak grows to be the 
largest peak These three peaks are also visible upon 555 
excitation while 515nm and 565nm excitation yields just 
the 615 and 679nm peaks Upon 632nm excitation (see 
fig 2 8) the 679nm peak has red shifted to circa 685nm 
In fig 2.9 the fluorescent peaks and their sensitivity 
limits are outlined
Excitation
(nm)
Emission
(nm)
Sens Limit 
(/xg/ml)
410 580 3 16x10'7
615 - 9 0x10 8
679 1 0x10'3
515 615 3 1x10'6
679 5 0x10'3
555 580 1 7x10'3
615 1 7x10'*
679 7 9xl0'3
575 615 1 0x10'2
679 2 4x10'2
632 685 0 36
Fig 2 9 Table of fluorescent sensitivity levels
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upon 410nm excitation 
Concentration•lpg/ml
Fig 2.7 Emission Spectrum of Hp + 
upon 632nm excitation 
Concentration 10/xg/ml
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The results obtained in fig 2 6 for the excitation 
spectra of Hp duplicate the results reported by Andre'oni 
and Cubeddu in 1983 (26) Richelli and Grossweiner (29) 
report a similar excitation spectrum for Hp in a phosphate 
buffer solution As a number of outside factors such as 
shifts in pH, temperature and age of solution, can 
influence porphyrin spectra, it is not exactly valid to 
compare results from different authors However Andreoni 
(HpD in water) (26), Doiron (HpD in fetal calf serum) (27) 
and van der Putten (HpD in serum) (54) have all reported 
similar excitation spectra for HpD with a circa 5nm red 
shift From fig 2 6 it is apparent that the excitation 
band centred in the red (625nm) is about 75 times smaller 
than the violet excitation peak (410nm) This is due to 
the low absorption of Hp molecules in the red spectral 
region
The emission spectra obtained in this chapter reveal 
three fluorescent emission peaks for Hp at circa 585, 615 
and 678nm The in vivo detection of these fluorescent 
wavelengths can thus be used for the identification of 
tumourous tissue in techniques such as fluorescent 
endoscopy The sensitivity limits obtained for these 
fluorescent peaks (see fig 2 9) provide an indication as 
to the relative efficiency of each of the excitation peaks 
for the detection of Hp fluorescence Concentrations of up 
to lfj.g of HpD per gram of tumour have been reported to 
accumulate in tumourous tissue (27) From fig 2 9 it is
2 6 3 Discussion
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seen that sensitivity limits well below this figure are 
obtained for each of the excitation wavelengths Although 
these figures represent the detection of in-vitro 
fluorescence under ideal circumstances they indicate that 
each of the excitation wavelengths investigated could be 
effective for the in-vivo detection of tumours including 
the red 632nm wavelength proposed in chapter 1
2.7 Conclusion
In this chapter the photosens itising dye 
haematoporphynn was discussed. Its chemical structure was 
briefly outlined and its properties as a localiser and 
photosensitiser are described The mechanisms by which it 
is effective for both the detection and therapy of cancer 
tumours upon photo-stimulation were then briefly described
Haematoporphyrin derivative as its name suggests is a 
derivative of the pure Hp. Both compounds have the same 
photo physical properties although HpD is a better 
localiser than Hp For this reason the commercially 
available form, Photofrin II, is currently the most common 
photosensitiser used in clinical trials Photofrin II is 
very expensive and the extraction of HpD from Hp is a 
complex chemical process. Thus it was considered that for 
in vitro fluorescent detection tests, Hp can be used as a 
model for the clinically popular HpD
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(In fig 2 6 five excitation peaks for Hp were located 
at 410, 515, 555, 575, and 625nm respectively Of these 
the Soret Band (405nm) is by far the largest
From table 2 9 it is obvious as to why the Soret Band 
is the most commonly utilised excitation wavelength in 
fluorescent endoscopy Extremely low concentrations of Hp 
in solution are detectable upon excitation at this 
wavelength In this regard Hg arc lamps and Kr-ion lasers 
have been used in clinical situations (see chapter 1) The 
main disadvantage with Soret Band excitation is that 
violet light has poor penetration in tissue This makes it 
impossible to detect bloody tumours or tumours beneath a 
layer of healthy tissue Similarly violet excitation 
stimulates a large auto-fluorescent signal (see chapter 1) 
from healthy tissue This signal known as
auto-fluorescence tends to mask the HpD fluorescence and 
hinder the detection of tumourous tissue
The excitation peaks at 515, 555, and 575nm have
better penetration in tissue than violet light Argon ion 
lasers with emission at 514nm and tunable dye lasers with 
emissions close to the 555nm and 575nm have all been 
investigated as possible sources for fluorescent 
endoscopy Indeed it can be seen from fig 2 9 that quite 
low concentrations of Hp can be detected using these 
wavelengths. These wavelengths are generally not used in 
clinical studies because they stimulate a considerable
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auto-fluorescent signal from the Healthy tissue layers 
surrounding the tumour
The use of He-Ne laser light (632 8nm) as excitation 
source in fluorescent endoscopy has been recently proposed 
(20) The advantages of using He-Ne light are outlined in 
chapter 1 and are good penetration in tissue, low
auto - fluorescence, and the fact that 630nm is the 
wavelength used in photodynamic therapy of tumours A 
sensitivity limit of 0 36jug/g has been obtained in this 
chapter for the 632nm excitation of Hp in solution This 
is much higher than the limit obtained for Soret 
excitation This means that much lower concentrations of 
Hp can be detected upon violet excitation than upon He-Ne 
excitation. However violet light will only propagate in 
superficial tissue layers while 632nm light can propagate
deep into tissue This suggests that He-Ne laser
excitation may be effective for the detection of tumours 
lying deep within a healthy tissue bed One such cancer is 
the early small cell carcinoma of the 
tracheo-bronchial tract. Such tumours could not be reached 
by violet excitation light The sensitivity limit of He-Ne 
light for Hp detection at 0 36pg/ml is still lower than 
the l^ tg/g concentration of HpD quoted to accumulate in 
tumourous tissue In the light of these facts it was
considered that further investigation of the use of He-Ne 
light for the detection of deep lying tumours was 
justified
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Chapter 3
SYSTEM DESIGN AND ANALYSIS
3 1 Introduction
In chapter 1 the topic of fluorescence endoscopy was 
introduced and several techniques for its use in cancer
diagnosis were outlined A review of clinical procedures
found that the use of blue excitation light resulted in a 
high proportion of false diagnoses The use of red 
excitation light has been suggested in a recent paper (20) 
The authors claimed that the use of red excitation light 
has significant advantages over blue light and would reduce 
the number of false diagnoses In this chapter the 
suitability of using red He-Ne laser light (632 8nm) as 
excitation source in fluorescence endoscopy is 
investigated
There are two main disadvantages inherent in the use 
of He-Ne excitation light Firstly, He-Ne lasers have 
generally very low power outputs ( typically l-10mW )
Secondly, as has been shown in chapter 2, the excitation
peak of Hp at 630nm is very small compared to that of the
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most commonly utilised blue wavelength i e 405nm Similarly 
the Hp fluorescence stimulated with He-Ne excitation was 
found to be very weak in comparison to that obtained for 
other excitation wavelengths
In this chapter a system is developed for the 
detection of in-vitro Hp fluorescence using a He-Ne laser 
as excitation source The system is designed, on the basis 
of the results obtained in chapter 2, for the detection of 
low level fluorescence signals It is constructed using 
readily available pieces of laboratory equipment and 
although the system is designed for the detection of 
in-vitro Hp fluorescence it could easily form the basis of 
a clinical instrument for the detection of tumours via 
fluorescence endoscopy The system incorporates a 
fibre-optic bundle and fluorescent detection is achieved by 
means of a photomultiplier tube and lock-in amplifier , 
chosen for their ability to detect low level light signals 
In the following sections a theoretical analysis of the 
performance of the system is presented and experiments are 
carried out to determine the sensitivity limit of the 
system for the detection of Hp fluorescence ( i e the 
lowest concentration of Hp for which fluorescent detection 
is possible) In this manner the design and performance of 
the instrument can be assessed and the suitability of using 
a He-Ne laser as excitation source in clinical fluorescence 
endoscopy can be investigated
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Fig 3 1 Schematic diagram of the fluorescent 
detection apparatus
3 2 Apparatus
A  simplified diagram of the experimental apparatus 
utilised in this chapter is presented in fig 3 1 A 5mW 
He-Ne laser is used to excite a Hp solution contained 
within a glass cuvette The laser light is first passed 
through an optical chopper which modulates the light at a 
frequency of 200Hz Experiments on the system reveal 
little variation in detected Hp fluorescence with chopping 
frequency For this reason a convenient frequency of 200Hz 
was chosen As all experiments were carried out in a dark 
room stray frequency components from overhead fluorescent 
lights did not interfere with the detection electronics
In order to simulate the use of a fluorescent 
endoscope the laser light is conveyed to the Hp solution 
via a single 600pm diameter excitation fibre The light is 
focussed onto the fibre by means of a lens (focal length = 
3cm). By placing a photo-diode alternately at the optical 
chopper and at the distal end of the fibre a fibre-coupling 
efficiency of 0 8 was measured The light leaving the distal 
end of the fibre is coupled directly into a 1cm thick 
cuvette containing the Hp + H20 solution The resultant 
fluorescent and backscattered excitation light fluxes are 
collected by the fibre-bundle and conducted to a 
filter-holder which is located between the fibre-bundle and 
the photocathode of the photomultiplier tube (PMT). Two 
optical filters are then used to alternately transmit these 
light fluxes to the PMT
The light signals are detected by the PMT and passed
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to a lock-in amplifier The lock-in receives a reference 
signal from a slotted opto-switch located on the chopper 
and amplifies only those signals in phase with the chopped 
laser light The amplified signals can then be read from 
the digital display of the lock-in In this manner a ratio 
of scattered fluorescent signals is obtained It was
decided to monitor this dimensionless ratio as a means of 
fluorescent detection as many problems that would otherwise 
be encountered in clinical work are thus eliminated (see 
3 2 6)
In assembling the apparatus used in this experimental 
set-up the cost and availability of equipment was a 
consideration In the detection system boxcar averaging or 
photon counting techniques can equally be used to obtain a 
ratio of scattered fluorescent light signals The choice 
of a lock-in together with the other pieces of equipment 
used in the instrument represent the use of common and 
readily accessible pieces of laboratory equipment In the 
following sections the design and performance of the 
instrument is described in more detail
3 2.1 The Fibre-Bundle
A fibre-bundle was constructed for experimental use in 
this chapter The bundle consists of a single 600/zm 
diameter excitation fibre surrounded by a cluster of 200;um 
diameter collection fibres (core diameters are 570 and
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190pm respectively) The numerical aperture (NA) of both 
the excitation and collection fibres is 0 44
A theoretical examination of the detection efficiency 
of the fibre-bundle was undertaken in order to estimate the 
amount of fluorescent light sampled by the fibre-bundle
The He-Ne laser light leaving the distal end of the 
excitation fibre will define a cone as it enters the 
sample
R
SA
Fig 3.2 Light cone leaving excitation fibre
where SA = area of illumination (area at base of the cone)
R = radius of circular area SA
P = height of cone (i e distance from fibre-tip)
n = refractive index of medium (for H O n « 1 33)
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t 2a
Fig 3.3 Schematic Representation of excitation and 
collection light cones within the cuvette
Excitation Collection
Fig 3 4 Excitation and collection light cones with 
corresponding overlap volume
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Fig 3.5 Head-on view of excitation and collection cones 
at any point within the cuvette
The solid angle (Q) of this cone is defined as the 
surface area at the base of the cone divided by its 
distance from the fibre-tip squared The solid angle can be 
expressed as a function of the numerical aperture of the 
fibre and the refractive index of the medium into which the 
light is coupled i e
II = = —  (Steradians) (1)
#  I
=> SA = f) P2 (cm2) (2)
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Similarly there is a cone at each collection fibre 
from which fluorescent and backscattered excitation light 
will be collected into the fibre The overlap between the 
input and collection cones is the region of solution from 
which fluorescent light is sampled by the fibre-bundle The 
geometry of the situation is shown in fig 3 3
In order to gain an expression for the amount of 
fluorescence produced in the overlap region the region is 
divided into thin slices of equal thickness The amount of 
fluorescence stimulated within a thin slice of solution 
can be shown (33) to be approximated by the equation
F  =  I o  ( 2  3€cAx) <f> (3)
where
I o  = excitation irradiance (mW/cm )
t = molar extinction coefficient (cm 1 per pg/ml)
c = concentration of Hp in solution (pg/ml)
Ax = thickness of slice (cm)
4> = fluorescence efficiency
The fluorescent irradiance emitted from each slice can 
be calculated from (3) and the total fluorescence produced 
in the overlap region obtained by summing the contributions 
from each slice
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The surface area at any point within the slices is
assumed to be elliptical (see fig 3 4) In order to
2calculate the excitation laser irradiance (Io, mW/cm ) 
within each of these slices the surface area at the centre 
of each of these slices must be obtained
The surface area of an ellipse is defined as Ilab 
where ,
a = point where the ellipse intersects the 
horizontal axis and 
b = point where the ellipse intersects the 
vertical axis (see fig 3 5)
From fig 3 3 it is apparent that
d - 2(d - R) _ 2R - d 
3  2 2
also from fig 3 5
b2 - R2 - (R - a)2
=> b = (R2 - (R - a)2) 1/2
b = (R2 - d2/4)1/2
where
R = radius of the circle at the base of the 
collection and excitation fibre cones at any 
point P from the fibre-tips 
d = distance between the excitation and collection 
fibre centres.
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Thus the surface area at the centre of any slice within the 
overlap region can be expressed as
S - ÏÏ £ 2- j X [ (R2 - d2/4)1/2 j (cm2) (4)
Po is the laser power (mW) leaving the distal end of the 
excitation fibre It is assumed constant over the thickness 
of the sample, light absorption is ignored as the sample is 
dilute The excitation laser irradiance (mW/cm ) within 
each of the slices can therefore be expressed as
I o  (mW/cm2)
The value for I o  thus obtained can be slotted into 
equation (3) in order to obtain the amount of fluorescence 
produced in each slice. The total fluorescence produced in 
the overlap region is then obtained by summing the
contributions from each slice
Not all the fluorescence emitted in the overlap region
however will be detected by the fibre-bundle In order to
calculate the amount of fluorescence sampled by the bundle 
the solid angle which each slice within the overlap
region subtends to the collection fibres must be 
considered
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The fluorescent emission from each slice is assumed to
be constant over all angles from 0 to 211 steradians The
2fluorescent irradiance from each slice expressed in mW/cm 
per steradian is thus F/2II
Thus the fluorescent power (mW) incident on the fibre 
from each slice in the overlap region can be expressed as
F n  R f 2
p  _  ---------  — _ ( n Rf2)
2n k2
where Rf = radius of collection fibre cone
k = distance between the centre of the slice 
and the collection fibre face 
(k - (P2 + d2/4)1/2)
2 2II Rf / k = solid angle of the collection fibre in
steradians as viewed from the centre of 
the slice
Pc must be calculated for each of the slices in the overlap 
region and the contributions summed in order to gain an 
expression for the total fluorescent power incident on the
collection fibre i e
no of slices 
I P (TOT) = X
0
A computer program has been developed which calculates 
P(tod by means of the technique outlined above Fig 3 6 
is a plot of P(tot) as a function of d, the separation
between the centre of the excitation and collection fibre
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Fig 3.6A plot of detected fluorescent power versus 
distance from the excitation fibre
Fig 3-7 A head-on view of light leaving a fibre-bundle 
exactly similar to the one described above.
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A head-on view of light emerging from a fibre-bundle 
similar to the one described in this chapter is presented 
in fig 3 7 In the analysis heretofore the collection 
efficiency of only one collection fibre has been
discussed From fig 3 7 it is apparent that there are 6
fibres m  the inner ring of the fibre-bundle Thus the 
total fluorescent power sampled by the inner ring of the 
fibre-bundle is 6 x Pctot) From fig 3 7 values of Pctotj 
for each of the outer rings of fibres can be obtained 
Finally by slimming the contributions from each of the
rings a value for the total fluorescent power sampled by 
the fibre bundle can be obtained For the sake of
simplicity the effects of oversampling i e one collection 
fibre cone sampling a region of the excitation cone that 
has already been sampled by another collection fibre is 
ignored
For an incident light power of 4 mW coupled directly
into a 1cm cuvette, containing a solution of Hp + IHD
(concentration lpg/ml), a sampled fluorescent power of 2 8 
- ^x 10 mW is obtained The design of the bundle was based 
on the principle of maximising P<tot) by minimising the 
distance between excitation and collection fibres d Thus 
200pm diameter collection fibres were used Fibres of a 
smaller diameter were considered too brittle for use
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3.2 2 Filter Characteristics
The collection fibres m  the fibre-bundle serve to 
convey the fluorescence and backscattered excitation light 
to the filter-holder This filter-holder alternately holds
(1 ) a narrow band-pass interference filter centred at 
633nm and which transmits only the backscattered 
excitation signal
(ii) a wratten gel no 35 filter which only transmits 
the fluorescent signal
In fig 3 8 the transmission spectra of these filters are 
presented The interference filter allows 60% transmission 
at 632 8nm , and no transmission after 650nm The no 35 
filter allows 10% transmission at 655nm (the fluorescent 
peak of Hp) , but continues to allow transmission up to
710nm This allows for the detection of the integrated
fluorescence emission from 650-710nm After 660nm it is
only the tail of the fluorescent peak that is detected The 
fluorescent light power transmitted through the no 35
filter and incident on the photocathode of the PMT can be 
expressed as the fluorescent power sampled by the 
fibre-bundle multiplied by the transmission of the 
collection fibres (80%) and the transmission of the no 35 
filter at the fluorescent wavelength (10%) i e.
F - 0 1 x (0 8 x 2.8 x 10'*) - 2 2 x 10'5mW
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WAVELENGTH (nm)
Fig 3 9 Visible light transmission (%) plotted against 
wavelength for (1) Interference filter (2) No.35 Wratten
Gel filter
3 2.3 Detection In choosing a photodetector for the 
system it must be borne in mind that the fluorescent signal 
is very small Thus the appropriate detector must combine 
the following factors
(1) good response m  600-700nm region of the 
spectrum,
(2) high Cathode Radiant Sensitivity (CRS),
(3) high gain,
(4) low dark current;
(5) high Signal to Noise ratio (S/N).
Other factors to be considered are cost, ease of
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incorporation into the experimental set-up, and power 
supply requirements PMT's were chosen over solid state 
detectors such as avalanche photo diodes because of their 
low dark currents typically compared to the latter devices. 
Typical values for PMT dark currents are of the order of 
1-lOnA
In Table 3.1 the response of a number of commercially 
available PMT's are assessed The figures used are all from 
manufacturers specifications, and the PMT's assessed are 
all chosen because of their good response in the 600-700nm 
region of the spectrum The anode currents are calculated 
for an incident light power of 2 2 x 10 5mW i e the 
fluorescent light power calculated as incident on the 
photodetector from our model calculations
MAKE R S 
(mA/W)
Ik
(mA)
GAIN l a
(mA)
COST
TE 9798 28 4 2 6e"6 1.3e~ 6 3 3 549
TE 9828 28 4 2 6e~6 1 Oe6 2 6 582
TE 9973 20 3 5e"6 1 3e6 4 6 356
TE 9658 44 1 3 *5 0 6e6 7 8 950
TE 9659 46 1 9e" 5 0 7e6 11 2 1067
HAM R928 34 1 6e~ 6 1 Oe7 16 148
HAM R758 65 2 9e" 6 1 6e5 0 47 401
l a  = Anode Current Ik = Cathode Current 
R S = Radiant Sensitivity TE = Thorn EMI HAM = Hamamatsu
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For our application the HAM R928 seemed the best 
option because of its low cost, low power supply 
requirements and its high g a m  and high anode current
The resultant anode current from the PMT is sent to a 
Stanford Research Systems SR510 lock-in amplifier where the 
signal is converted to a voltage and amplified The lock-in 
output can then be read from a digital display
3.2.4 Ratio Method of Fluorescent Detection
The ratio method of Hp detection is a novel concept in 
fluorescent endoscopy (20) It is reported (20,2) that it 
should eliminate the effects of certain parameters on the 
detection of fluorescence The use of the filter-holder in 
this system allows for the separate detection of Hp 
fluorescence and back-scattered He-Ne light The ratio of 
these two signals is recorded and used as the basis for 
fluorescent detection The main advantages of the ratio 
method appear to be that fluorescent detection becomes 
independent of
(i) fibre-bundle to sample distances
(ii) variations in sample topography
(iii) variations in the efficiencies of the 
detection and excitation systems
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By placing the appropriate filter in the filter-holder 
a reading can be obtained from the digital display of the 
lock-in for each of the light signals The ratio is then 
expressed as a percentage as follows
R (%) - Fluorescent Signal x 1Q()
Backscatter Signal
From the filter characteristics it is estimated that 60% of 
backscattered laser light is transmitted through the 
interference filter while 10% of the fluorescent light is 
passed through the no 35 filter Thus in order to obtain an 
appropriate value for the ratio of fluorescent to 
backscattered light at the sample the ratio obtained from 
the lock-in was multiplied by 6
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It has been reported that in-vivo HpD concentrations 
as low as 1/ig/ml have been measured in tumourous areas 
(27). Thus if the use of He-Ne excitation light is to 
become a valid alternative in fluorescent endoscopy, 
detection systems must be developed which detect He-Ne 
induced HpD fluorescence from concentrations of the dye 
less than 1/ig/ml. In order to determine the sensitivity of 
our system for the detection of Hp fluorescence a series of 
experiments were carried out The objective was to obtain 
the lowest signal ratio which could be identified by the 
system and thus determine the lowest concentration of Hp 
which could be detected Hp was utilised in these 
experiments as a convenient model for the clinically 
popular HpD for the reasons outlined in chapter 2 In this 
way the efficiency of using a He-Ne laser as excitation 
source can be assessed
3 3 1 Procedure
In these experiments the system was used to detect 
fluorescence from solutions of Hp and methanol (MeOH) and 
Hp and H^O The experimental set-up is as described in 
section 3 2 and outlined in fig 3 1 ,The He-Ne laser light 
is coupled directly from the fibre-bundle to a cuvette 
containing Hp in solution Fluorescent detection is by 
means of the ratio method as outlined in section 3 2 4
3.3 Experiments
The solutions of Hp + H20 and Hp + MeOH were prepared 
according to the procedures described in chapter 2 in order 
to preserve a uniformity of photophysical properties 
throughout the experiments. The concentration of Hp in 
solution was progressively lowered and the ratio of 
backscattered laser light to fluorescence is noted from the 
lock-in amplifier. In this way plots of signal ratio versus 
Hp concentration for both Hp in methanol and Hp in H20 were 
obtained.
3.3.2 Results and Discussion :
In fig 3.8 and 3.9 typical results obtained from these
experiments are plotted. Each point on the plots represents
the average of three separate measurements and error bars
are included for accuracy. Both plots display a rapid
fall-off of signal ratio with Hp concentration. In general
the signal ratio for concentrations of Hp in MeOH is higher
than that of similar concentrations of Hp in H 0. This is
r  2
due to the superior solubility of Hp in MeOH resulting in 
an increased fluorescent quantum efficiency for Hp in MeOH. 
Both plots exhibit a marked tailing off at a ratio of 
0.04%. This ratio can be considered to be the lowest signal 
ratio that can be distinguished by the system. For the case 
of Hp + MeOH this corresponds to a concentration limit of 
0.01 pg/ml while for Hp + H ^  it corresponds to 0.1 pg/ml. 
The sensitivity limit of 0.1 /ig/ml obtained for Hp + H2Q is 
lower than the 0.36/xg/ml limit obtained for 632nm
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excitation using the spectrophotometer in chapter 2 The 
sensitivity limits obtained illustrate that very low 
concentrations of Hp can be detected by this technique 
Similarly the use of a He-Ne laser as excitation source in 
the system results in the detection of Hp concentrations 
well below the lpg/ml concentration of HpD measured to 
accumulate in tumourous areas (27)
3 4 Other Experiments
The use of a fibre-bundle in this system limits the 
amount of detected fluorescence Concentration curves were 
obtained for the system without the fibre-bundle A lens 
was used to focus the fluorescence from the cuvette onto 
the photocathode of the PMT Sensitivity levels of 1 x
-  410 pg/ml were obtained for Hp + H^O Thus the use of the 
fibre-bundle reduces the sensitivity level of the system by
3a factor of 1 x 10
In another set-up a scanning monochromator was placed 
between the sample-holder and the PMT Again fluorescent 
detection was undertaken without the fibre-bundle and a 
lens focussed the fluorescent light from the cuvette onto 
the entrance slit of the monochromator The monochromator 
scanned between 600 and 700nm and a dual peaked spectrum 
obtained with the excitation peak at 632nm and an emission 
peak at 655nm The peak-height of the emission peak was 
recorded for progressively dilute solutions of Hp + H20 and 
a sensitivity limit of 8 x 10 5pg/ml obtained. This is a 
factor of 1 2 x 10 times more sensitive than the system
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with the fibre-bundle This scanning monochromator system
could also utilise the ratio method of fluorescent
detection as outlined in this chapter by recording the
ratio of the excitation peak height to that of the emission
peak If a fibre-bundle were added to this set-up the
-3sensitivity would be reduced, by a factor of 1 x 10 and 
would thus equate to the system described in this chapter 
The use of a scanning monochromator detection system in 
clinical situations would be infeasible however as for each 
point sampled in (for example) the trachea, the 
monochromator would have to scan across the region of the 
spectrum 600-700nm This would make the duration of a 
typical examination intolerable
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Fig 3 8 Concentration of Hp m  a solution of Methanol 
plotted against signal ratio
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Fig 3 9 Concentration of Hp in a solution of H 0
2
plotted against signal ratio
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The purpose of this chapter was to investigate the use 
of a He-Ne laser in fluorescence endoscopy For this reason 
a system was developed for the in-vitro detection of Hp 
fluorescence
In order to simulate endoscopic conditions a 
fibre-bundle was used in the system to both transmit the 
excitation signal and collect the resultant fluorescence 
In designing the fibre-bundle careful consideration was 
taken of both fibre-bundle geometry and fluorescent 
collection efficiency. A theoretical examination of these 
factors lead to the design of a bundle which minimised d, 
the distance between the excitation and collection fibres, 
in order to maximise the detected fluorescence. For 
convenience the fibre-bundle used m  this system was 30cm 
in length however its diameter of 0 9cm was chosen in order 
that the bundle could fit adequately into most clinical 
endoscopes
In this system, fluorescent detection is quantified by 
means of the ratio method (see 3 3 5) This technique of 
fluorescent detection should prove of great benefit in 
clinical circumstances as it predicts the irradication of 
temporal variations in fluorescent detection due to changes 
in topography, tumour to bundle distance and system 
excitation and detection efficiencies
Experiments on this system have shown that in-vitro 
concentrations of 0 01 /zg/ml for Hp in methanol and 0 1 
pg/ml for Hp m  H^O can be detected. These limits are below
3 5 Conclusion
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the 1 fj,g/ml concentration of HpD quoted (27) to have been 
measured in tumourous areas 48 hours post injection This 
seems to indicate that this system which incorporates a 
He-Ne laser as excitation source may be effective for the 
detection of tumours via fluorescent endoscopy It must be 
stressed , however, that the sensitivity limits of the 
system were obtained for the detection of in-vitro Hp 
fluorescence from a glass cuvette and that in-vivo 
conditions may be significantly different However the 
detection of low concentrations of Hp m  solution using a 
He-Ne laser as excitation source is encouraging
In conclusion a system has been developed which uses a
/
He-Ne laser as excitation source and can detect low 
concentrations of Hp in solution The system was designed 
for the detection of in-vitro fluorescence however it could 
easily be adapted to form the basis of an instrument for 
the detection of intra-cavitary tumours via fluorescence 
endoscopy In this regard the use of the He-Ne laser and 
the ratio method of fluorescent detection could present the 
clinician with significant advantages over conventional 
techniques of fluorescent endoscopy
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Chapter 4
LIGHT-TISSUE INTERACTION
4.1 Introduction
A knowledge of how light behaves in biological tissue 
is fundamental to a number of areas in photomedicine e.g. 
laser surgery, PDT, fluorescence endoscopy etc. In order to 
fully characterize the clinical performance of the 
apparatus described in chapter 3, it is necessary to take 
account of the interaction of light with tissue. In this 
chapter an overview is given of the main models used to 
describe the interaction and an appropriate choice is made 
to describe the propagation of He-Ne laser light through 
tissue. This will then form the basis in chapter 5 for a 
comprehensive model of the performance of the apparatus in 
a simulated clinical setting.
4.2 Tissue Optics
Biological tissue is a complex scattering and 
absorbing medium with a higher refractive index than air 
(35). Thus when a light beam reaches an air/tissue boundary 
a small portion of the flux will be reflected. The 
remainder of the light (typically 95-96%) penetrates the
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tissue and encounters multiple absorption and scattering 
centres The extent of scattering and absorption depends on 
the wavelength of the incident light and the type of tissue 
involved Most tissues are highly scattering and a large 
portion of the light flux is backscattered from the tissue
An accurate description of the propagation of light 
within tissue is difficult An estimate of the light 
distribution in tissue can be obtained by solving the 
radiative transport equation This poses a formidable 
mathematical problem for which Chandrasekhar (37) has 
proposed a general solution
4 3 Transport Theory
Radiative transport theory has proved a popular and 
effective method for the study of scattered light in turbid 
materials In the past it has been used to describe such 
widespread phenomena as atmospheric optics, oceanic optics 
and astrophysics (36) The theory involves the general 
solution of the transport equation which, if we assume the 
light incident on a slab geometry, has been defined by 
Chandrasekhar (37) as (see overleaf)
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J T  / s ( cr +  a )
> M/ / • NT/  \ .  ^ S / i \H ------  ■ ^ - =  -(<7 +  a ) I ( z f / i )  +   =------------  ( 1 )
G Z  a s  Z
X J dp1I(z,/i)p(p,M1 )
where I(z,/j) ■= radiance at depth z 
H = Cos 6
8 — angle between the direction of scattering
and the normal (see fig 4 1) 
pi/i,^1) = phase function for light scattering from 
the direction p 1 = Cos BX into y. = Cos 6 The 
phase function is assumed to depend on the 
angle between n and fj1 only The 
normalization condition imposed on p(p./i1) 
is •
l  a
s
2 J a + a-1 a s
where a = the absorption coefficient of the 
medium and a = the scattering coefficient.
2
Fig 4 1 d - angle between direction of scattering
and the normal
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Although this equation provides a very accurate 
description of tissue optics the general solution of the 
equation is not known In photomedicine simplified but 
plausible approximations of the equation have been applied 
to light-tissue interaction In this chapter three such 
models are discussed and their results compared These are 
Beers Law, the Kubelka-Munk theory and the diffusion 
approximation The quantity of interest in these models is 
the light energy fluence rate within the tissue This is 
defined as the t o t a l  energy  o f  the  photons  i n c i d e n t  p e r  
second on a small  sph ere  c e n t r e d  a t  t h a t  p o i n t  and d iv id e d  
by the  c r o s s  s e c t i o n a l  area o f  the  sphere (38) These 
models are discussed in depth below
4.3 1 Beers Law This is the simplest of the models and 
states that light intensity is exponentially attenuated as 
it passes through tissue ^ and is given by
I(z) = Io e'T(z) (2)
I(z) = intensity at depth z
Io = incident intensity (ie at z = 0)
T = attenuation coefficient
T can be easily calculated by measuring the total 
transmission through a sample of tissue. Despite its 
simplicity Beers Law has been applied successfully to
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several tissue Its inherent disadvantage lies in the fact 
that the calculation of T does not distinguish between 
scattering and absorbing events For this reason, the 
general rule of thumb when applying Beers Law is that it is 
only valid when the absorption coefficient is much larger 
than the scattering coefficient This is true for most 
applications of the CO^ , Excimer and Er.YAG lasers when 
the penetration depth is less than 40pm (35)
4 3 2 Kubelka-Munk
The Kubelka Munk (KM) theory (39) is an extension of 
Beers Law to take account of light scattering It is named 
after the authors of a 1931 paper which proposed the theory 
for the description of the optical properties of paint 
Since then it has been used to model a wide variety of 
processes In the field of light-tissue interactions van 
Gemert and Hulsbergen-Henning (40) have used it to describe 
light interaction in port-wine stains while Wan et al (41) 
have applied it to skin scattering and absorption m  a 
general sense
In the KM theory a diffuse light is incident on a 
tissue slab and the irradiance throughout the tissue is 
assumed constant in all directions (i e isotropic) Two 
light fluxes, one travelling in the forward direction 
(F+(z)) and one in the backward direction (F-(z)) are used 
to describe the energy fluence rate at depth The rate of 
change of forward flux with depth is defined as the amount
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of scattered backward flux less the amount of forward flux
which has been either scattered or absorbed Similarly the
rate of change of backward flux is given by the scattered 
forward flux less amount of scattered or absorbed backward 
flux These fluxes can be defined by the differentials (39)
- (K+S)F+(z) + SF-(z) (3)
'd| ^ )= - (K+S)F-(z) + SF+(z) ' (4)
and the energy fluence rate defined as
i>(z) = 2(F+(z) + F-(z) ) (5)
K and S are the KM coefficients of absorption and 
scattering and are not the same as the absorption and 
scattering coefficients of tissue They have been shown to 
be related to the diffuse reflectance (Rd) ,and transmission 
(Td) properties of tissue (54) As it is difficult to 
measure the diffuse reflectance and transmission through 
tissue information on K and S for biological tissue, is 
scarce and often has to be estimated with considerable 
inaccuracy Other problems with the model are that iJ is 
only valid when dealing with diffuse irradiance in a 2-D 
geometry The model is popular, however, because it is 
simple and convenient to use and provides an approximate 
solution Van Gemert and van der Putten (42) used the 
method to model the detection of subcutaneous tumours by 
HpD fluorescent detection
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The diffusion approximation of the transport equation 
has been widely used for light propagation in biological 
media especially where scattering dominates absorption 
(35, 36, 43) It is the only one of the models mentioned 
here which can accommodate a collimated light source If 
the case of a collimated laser beam incident on a slab of 
tissue is considered then the diffusion theory makes the 
assumption that the radiance at any point m  the tissue 
can be expressed as
I(z,p) = Ic(z)6(x) + Id(z,n) (6)
where
Ic(z) = collimated radiance at depth z 
Id(z,p) = diffuse radiance at depth z and
8 — angle between the direction of
scattering and the normal 
S (x) = delta function with x = 1-p Thus
S (x) = 0 everywhere except at x = 0 
where 6(0) = 1
p is defined as Cos 8 where 8 is the angle between the 
direction of light scattering and the normal Equation (6) 
thus states that the radiance at any depth z is given by
4.3.3 Diffusion Theory
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the collimated radiance at that point, which is zero in 
every direction except 0 = 0, plus the diffuse radiance at 
that point The diffuse radiance at depth is given by
Id(z) = <f>( z) + /^(z) (7)
where
<f>(z) = isotropic part 
tf(z) ■= anisotropic part
These assumptions make it possible to solve equation (1) 
(see van Gemert (43)) yielding the following coupled 
differential equations (seeoverleaf)
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dFc(z)
dz = - DFc(z)
dF+(z)
dz EF+ (z) + F (F-(z)) + BFc(z)
^ i z) = . F (F+ (z)) + EF-(z) - CFc(z)
F+(z) and F-(z) are the forward and backward photon fluxes 
respectively , while Fc(z) represents the collimated 
flux within the tissue The constants B, C, D, E, F are 
defined as follows .
B =
C = 
D =
as(2 + 3g)/4 
a (2 -3g)/4
(a + a ) 
a s
E = 2a + 0 75 {cr + (l-g)a } - <7
s  a
F = 0 75{cr + (l-g)or } - a
s  a
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Where
a = absorption coefficient (m 1)
a
a = scattering coefficient (m X)
g = anisotropy factor
The anisotropy factor g is introduced to allow for a 
slight anisotropic scattering of the diffuse flux and is 
defined as the mean cosine of the scattering angle This 
scattering angle 6 is the angle between the z-direction of 
propagation and the direction into which the light flux has 
been scattered upon impinging on a scattering centre (see 
fig 4 1) g can be varied to describe backward peaked (g = 
-1), isotropic (g = 0) or forward peaked (g = 1) scattering 
(Groenhuis et al (44))
In order to get an expression for the energy fluence 
rate, the three flux differential equations must be solved 
These equations were reduced (see appendix 1) using linear 
algebra to the following three simultaneous equations We 
acknowledge the assistance of Dr E Bouffet of DCU 
Mathematics Dept, in these calculations
F+(z) = ae~Dz(G) + /9eLz(F) + 7e'Lz(F) (8)
F- (z) - ae'Dz(H) + £eLz(J) + 7e"Lz(K) (9 )
Fc(z) - ae”Dz(I) + 0 + 0 (10)
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D, F, G, H, I, J, L, K are ail constants defined in 
appendix 1 oc, fi and û are constants and are determined by 
means of applying the appropriate boundary conditions to 
(8), (9) and (10). Star et al (38) proposed the following 
boundary condition for light incident on a tissue slab of 
thickness Z
F+(0) = 0 = F-(Z)
This states that no nett scattered light flux enters the 
medium at the boundaries To these can be added the 
condition that
Fc(0) = Io = incident light intensity of the laser
By obtaining expressions for a,  ft, and £ readily solvable 
equations are obtained for the light fluxes and the energy 
fluence rate at any distance z in the medium is obtained as 
follows
*(z) = 2(F+(z) + F-(z)) + Fc(z) (11)
The diffusion approximation of the transport equation 
is valid for optically dense and highly scattering media. 
As this appears to be the case for a wide variety of 
biological tissue its use for the description of 
light-tissue interaction is well-documented in the 
literature The inclusion of a collimated flux term in the
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model makes it suitable for modeling laser irradiation of 
tissue However at the tissue boundaries the model has been 
shown to be inaccurate This is because the model requires 
the presence of diffuse light fluxes within the tissue and 
at the boundary scattering is not dominant resulting m  a 
strong collimated flux Equation (11) can be readily solved 
with the unknown factors being a , a and g being obtained 
from the literature
4 4 Numerical Solutions
In order to chose the most effective model for the 
description of the propagation of He-Ne laser light through 
tissue, the models described in the previous sections were 
implemented in computer programs and numerically solved for 
different simulated tissues These programs were written in 
BBC Basic, compiled in RiscBasic and run on an Archimedes 
PC with maths co-processor installed
These programs were used to generate plots in which 
the three models are compared for the description of light 
propagation in tissues with
(i) dominant absorption
(li) equal absorption and scattering
(iii) scattering much greater than absorption.
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The optical coefficients used in these programs are 
obtained from the literature In obtaining optical 
coefficients for these situations, however, it is important 
to note that the KM coefficients are not the same as the 
transport coefficients used in the diffusion approximation 
and Beers law. However, Welch et al (35) have provided 
equivalent values for both sets of coefficients for the 
situations described above Fig 4 2 tabulates these values 
a and a are ^the transport coefficients with Beers Lawa s
attenuation coefficient given by T - a + a K and S area s
the absorption and scattering Kubelka-Munk coefficients 
respectively All values are expressed in cm 1
a a a s T K S Condition
10 1 11 10 8 0 33 Dominant Ab sorption
10 10 20 14 7 5 1 Equal S catt & Abs
1 100 101 2 0 75 DominantS cattering
Fig 4.2 Table of equivalent values for 
transport and KM coefficients
As the diffusion approximation model is the only model
t
which allows for a collimated flux term it is examined in 
more detail than the Kubelka-Munk or Beers Law models. 
Plots are generated of the three photon fluxes and the 
resultant energy fluence rate as calculated by the model. 
a (0.0013 mm *) and a (1 mm X) are chosen in order thata s
a « <  a and the scattering is considered to be 
predominantly forward peaked with g = 0 71 These
conditions have been chosen in order to replicate the
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conditions reported (35) as being prevalent for red light 
passing through tissue
The influence of the anisotropy factor g on the 
diffusion equation is investigated Plots are generated of 
fluence rates for g varied between 0 and 1 From the plot 
the performance of the model for the description of 
isotropic (g = 0) to highly forward scattering (g = 1) 
light propagation can be assessed
In figs 4 8 and 4 9 fluence rates are plotted for 
varying a and a respectively This yields an indication
a s
as to in which types of tissue the diffusion approximation 
represents a realistic description of the propagation of 
light.
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Fig 4.3 Beers law, KM, and diffusion models plotted against 
tissue thickness for dominant absorption (see fig 4.2).
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Fig 4.4 Beers law, KM, and diffusion models plotted against 
tissue thickness for equal scattering and absorption
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TISSUE DEPTH (m m )
Fig 4.5 Beers law, KM, and diffusion models plotted against 
tissue thickness for scattering dominant (see table 4 2)
TISSUE DEPTH (m m )
i
Fig 4.6 Energy fluence rate and the three photon fluxes 
plotted against tissue depth where a >>> a and g ■= 0.71
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Fig 4.7 Energy fluence rate plotted against tissue depth 
for g varied between 1 and 0.
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Fig 4.8 Energy fluence rate plotted against tissue depth 
for a varied between 0.1 and 1 x 10 4
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Fig 4 9 Energy fluence rate plotted against tissue depth 
for a varied between 1 0 and 0 06 mm 1
S
4.5 Results and Discussion
From fig. 4 3 it is apparent that when absorption 
dominates there is very good agreement between the models 
Beers Law then provides a very simple and effective 
technique for the description of light propagation in 
highly absorbent tissue When scattering and absorption 
begin to equalize (fig 4 4), however, discrepancies between 
the models begin to appear. In fig 4.5 where scattering is 
dominant Beers Law is shown to be increasingly inadequate 
for the description of light distribution This is because 
it fails to account for the broadening of the light beam 
within the tissue and it does not include a component to
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cater for backscatter The Kubelka-Munk theory similarly 
does not account for beam broadening and it cannot 
accommodate a collimated flux term This causes xt to 
overestimate fluence rates when scattering dominates 
Compared to Beers Law and the Kubelka-Munk theory the 
diffusion approximation appears to be the best of the three 
models for highly scattering tissue Its collimated flux 
term makes it suitable for describing laser-tissue 
interaction and it allows for beam broadening and 
backscatter
From fig 4 6 it can be seen that for highly scattering 
tissue the energy fluence rate within the tissue is greater 
than the incident irradiance (i e incident irradiance = 
Fc(0)). This phenomena is well documented and has been 
reported by Star (38) and Motamedi (45) amongst others It 
Is due to diffuse internal reflection and backscattermg at 
the tissue surface and is dependent on the absorption 
coefficient as can be seen from fig 4 8 where the fluence 
rate just inside the tissue is seen to drop markedly with 
increasing a This phenomenon can be compared to the
a
well-known "build-up" effect in Radiotherapy where the 
fluence rate of external beam radiation is observed to be 
greater just inside the tissue
In fig 4 6 the fluence rate is seen to reach a maximum 
within the tissue In fig 4 7 it is shown that this peak 
shifts further into the tissue with increasing g The 
reason for this is that as g increases transmission 
(forward scattering) increases and the local absorption
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as this propagation becomes more forward scattering the 
fluence rate peaks further into the tissue and decays more 
slowly when compared with a more isotropic medium At g = 1 
the light is totally forward scattered resulting in a 
fluence rate peak which extends up to 7mm inside the 
tissue, with the fluence rate at the tissue surface 
approximating the incident irradiance
Fig 4.9 indicates that as a decreases to the
S
magnitude of a the fluence plot collapses to a straight
a
line and total transmission is predicted as would be 
expected These plots seem to indicate that the diffusion 
approximation presents a cogent and logical description of 
laser-tissue interaction The shape of the plots obtained 
are confirmed theoretically by Yoon et al (1989) (46) and 
experimentally by Moes (1989) (47).
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methods for the modeling of light propagation in tissue
All three methods prove effective for specific 
applications The simplest method, Beer's Law, is 
applicable where absorption dominates scattering and has 
been used effectively for the description of the 
transmission of visible light below 600nm travelling 
through blood The KM theory is a more robust technique and 
has been used extensively in light-tissue modeling
Problems with the method include the fact that it only 
allows for diffuse irradiance and 2-D geometries It is 
also difficult to obtain accurate values for the K and S 
coefficients The diffusion theory is able to accommodate a 
collimated flux which makes it suitable for laser-tissue 
modeling It has been shown to be very effective for the 
description of conditions where scattering dominates
absorption The main drawback of the model is that it has
been shown, both by phantom studies and when compared to
other models, to be inaccurate at tissue boundaries The 
reason for this is that in highly scattering tissue 
propagation is strongly forward peaked (e g g = 0 71) Thus 
at tissue boundaries or at local inhomogeneities the model 
is unable to account for large backscattered signals caused 
by differences in refractive indices
The three models described in this chapter are not the 
only models currently in use for the description of light 
propagation in tissue. Several other techniques have
4.6 Conclusion
In this chapter an analysis was presented of several
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recently appeared in the literature These include the 
discreet ordinate approximation (45) of the transport 
equation and models which trace photon migration in tissue 
in a probabilistic fashion such as the lattice (55) and 
Monte-Carlo (56) techniques. These models are relatively 
complex and prove prohibitive in terms of computing time
In chapter 5 the diffusion theory is used to model the 
propagation of He-Ne laser light through bronchial tissue 
The diffusion theory is chosen because of its ability to 
describe laser interactions and situations where a » a
s  a
(which has been shown (35) to be the case for red light 
propagating through tissue) The quantity of interest in 
the model is the radiant energy fluence rate at depth and 
thus accuracy limitations at the tissue boundary have only 
a limited effect on the efficiency of the model
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A THEORETICAL DESCRIPTION OF A SYSTEM FOR THE 
PERFORMANCE OF FLUORESCENCE ENDOSCOPY
Chapter 5
5.1 Introduction
In chapter 3 the design of a system for the detection 
of Hp fluorescence was described. This system utilises a 
He-Ne laser as excitation source and introduces a novel 
method of fluorescence detection involving the 
determination of a ratio of fluorescent : backscattered
excitation light. The aim of this project is to investigate 
whether this system can be used as the basis of an 
instrument for the effective performance of fluorescence 
endoscopy.
Fluorescent endoscopy, as outlined in chapter 1, 
involves the location of intra-cavitary tumours via the 
detection of fluorescence from a tumour bound 
photosensitising dye. It has been shown (chapter 3) that 
the system is capable of detecting fluorescence from very 
low concentrations of Hp in solution. Also the ratio method 
assumes certain advantages over other techniques of 
clinical fluorescence detection. In this chapter a 
comprehensive mathematical model is presented which 
predicts the behaviour of an instrument, based on the
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system described in chapter 3, for the detection of small 
intra-cavitary tumours This model serves to assess the 
effectiveness of the instrument for tumour detection and 
presents a detailed sensitivity analysis in terms of such 
parameters as tumour size, concentration of 
photosensitiser, and thickness of overlying tissue. This 
should prove of great benefit in predicting clinical 
results and in the analysis of such m-vivo results The 
model is also designed to be adaptable to other systems and 
instruments of tumour fluorescence detection Similarly the 
model could be applied to light dosimetry considerations in 
photodynamic therapy, general laser surgery and other 
applications of lasers in medicine
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In this section the detection of a tumour using a 
clinical instrument based on the system described in 
chapter 3 is modelled The model assumes both the same 
excitation source (He-Ne laser) and the same detection 
apparatus ( PMT, lock-in amplifier and ratio method of 
fluorescent detection) as used in chapter 3 A clinical 
endoscope is used to transmit the excitation light to the 
site of the tumour and collect the resultant fluorescence 
This endoscope is assumed to comprise of a fibre-bundle 
exactly similar to the bundle designed in chapter 3. The 
only difference is that this bundle must of necessity be 
over 1 metre in length in order to access an inter-cavitary 
tumour.
The target or model tumour is assumed to be 
cylindrical m  shape and embedded in a mass of healthy
tissue (see fig 5 1) The dimensions of the tumour are
taken as diameter = 5mm, thickness = 0 5mm and overlying 
tissue thickness = 1 5mm These dimensions are chosen to 
represent the likely dimensions of early small cell
carcinoma of the tracheo-bronchial (TB) tract Such 
carcinomas develop initially in the submucosa and are thus 
separated from the lumen of the body tract by several
layers of epithelial tissue HpD is assumed to have 
selectively accumulated in the tumour with a concentration 
of 1/xg per gram of tumour while being totally absent in the 
surrounding tissue. The fibre-optic endoscope is assumed to
5 2 Model
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be located in the lumen of the of the body cavity with the 
excitation fibre positioned directly adjacent to the tumour 
(see fig 5 1)
Fig 5 1 Schematic representation of a tumour embedded in
healthy tissue
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For the sake of simplicity the process of tumour 
detection with the instrument can be broken down into the 
following sections
(1) The coupling of the excitation light from the 
He-Ne laser to deep within the tissue
(2) The propagation of excitation light through the 
overlying tissue to the tumour site
(3) The stimulation of the HpD within the tumour and 
the subsequent return of the fluorescence from the 
tumour to the tissue surface.
(4) The collection of the fluorescence that 
reaches the tissue surface, by the fibre-bundle 
and the detection system
In this chapter these sections will be dealt with 
separately
5 2 1 Excitation
In order to access locations deep within the body 
cavities a fibre-bundle of over 1 metre long must be used 
This fibre-bundle is assumed to be positioned within the 
lumen of the body tract 1 cm from the epithelial wall The 
epithelial wall of both the main body tracts (i e the 
tracheo-bronchial and the gastro-intestinal) are coated 
with a thick layer of mucus , secreted from ducts at the 
base of the cilia. Thus the light leaving the excitation 
fibre may be considered to be coupled into an aqueous
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environment This excitation light describes a cone as it
'leaves the excitation fibre The surface area of this cone
(SA) , at the epithelial wall determines the irradiance 
2(mW/cm ) of the excitation light which enters the tissue 
If the fibre-bundle is assumed to be identical in all
things but length to the one described in chapter 3 then
>
from chapter 3 we have the surface area at the tissue wall 
given by •
sa  = ( - y - f f - j  n x  (1  0 ) 2 (1 )
Where 0 44 is the numerical aperture of the excitation 
fibre and 1 33 is the refractive index of the medium into 
which the light leaving the fibre is coupled
Doiron reported a 25% light loss when coupling a 
Krypton-ion laser down a 1 metre length of fibre. Assuming 
a similar "worst case" coupling efficiency then if a 5mW 
He-Ne is used as excitation source the excitation light 
intensity entering the tissue is given by
Io = 75 = 10 9 mW/cm2 (2)D A
Generally, coupling efficiencies for red light will however 
be higher
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In equation (2) the light intensity entering the 
tissue is calculated In order to detect the tumour the 
light must travel through the overlying epithelial tissue 
before exciting fluorescence in the HpD marked tumour In 
chapter 4 several models for the description of light 
propagation m  tissue were outlined The diffusion 
approximation of the transport equation is considered the 
most appropriate model for the description of the progress 
of He-Ne laser light through the epithelial tissue for the 
following reasons
(1) It includes a collimated flux term which makes it 
suitable for the description of laser-tissue
interaction
(2) It has proved the most accurate model in the case 
of tissues with scattering coefficient (tr )
S
significantly larger than the absorption
coefficient (ct ) This is the case for a wide
a '
variety of biological tissues at 630nm , including 
bronchial epithelium tissue (see fig 5 2)
(3) a and a are easily measured for epitheliala s
tissue and values are well-documented in the 
literature (48).
(4) The model allows for the anisotropic perturbance 
of irradiance at depth. This makes it suitable for 
thick tissue slabs
In chapter 4 the diffusion approximation is broken down to
5 2.2 Light-Tissue Interaction
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the following three equations for the forward , backward 
and collimated photon fluxes respectively
dFc(z)
dz - (a + a )Fc(z)a s
“ - [2cr +0 7 5 ( a +  (l-g)<7 } - a ]F <z)GZ a a s a +
+ [0 75(ct + (l-g)ff } - * ]F (z) +a s a
Os (2 + 3g)Fc(z)
dF_(z)
—T  = - [2a + 0 75{ct + (l-g)a } - a ]F (z) +GZ a a s a
[0 75(a + (l-g)a } - a ]F (z) +a s a +
a (2 -3g)Fc(z)
4
These equations can be solved by recourse to linear
algebra as outlined in appendix 1 In this way a general
solution to the three simultaneous equations is obtained 
By applying the boundary conditions
F+(z =0) = 0 = F-(z = Z)
(Z is the thickness of the slab of tissue in which the
light is propagated) expressions for Fc(z), F+(z), and 
F-(z) are obtained These fluxes are expressed as functions 
of a , a and g the anisotropy factor The light fluence
rate can be calculated as in chapter 4 by means of the 
expression
i(z) = Fc(z) + 2(F+(z) + F-(z))
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In order to obtain the fluence rate of He-Ne light as 
it passes through tissue appropriate values of a , a anda s
g must be obtained. The anisotropy factor g is commonly 
taken as 0 71 for a variety of tissue types and wavelengths 
(47) Values of a and a were obtained from the scientific
a s
literature Wilson and Peterson (48) have published a table 
of tissue coefficients for a range of light wavelengths 
Fig 5 2 tabulates the coefficients quoted for 630nm light
a (cm X)a a (cm *)S Tissue
0 4 7 9 Cow Muscle
0 3 4.0 Chicken Muscle
1 0 17 0 Human Dermis
Fig 5 2 Optical coefficents of tissue at 630nm
The backscattered excitation light can be calculated by 
recording the value of the backward photon flux at a tissue 
thickness of zero (i e F-(z = 0)) Fresnel reflection at 
the tissue surface is neglected as identical refractive 
indices inside and outside the tissue are assumed
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Fig 5 3 Model of tumour as x-y lattice of point sources 
and corresponding lattice structure of the 
surface area of intersection (SA)
5 2.3 Tumour Fluorescence
In the last section it was shown how the energy 
fluence rate of He-Ne light is calculated as it passes 
through the tissue In this section we will examine what 
happens when the He-Ne light strikes the HpD marked tumour 
The first thing to be determined is the He-Ne energy 
fluence rate within the tumour It is assumed in this model
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that the tumour and the overlying tissue both have the same 
optical properties Thus if the location of the tumour 
within the tissue is known then the fluence rate can be 
determined at each point within the tumour
It is assumed that with respect to the excitation 
light the problem can be treated in a 1-D fashion and that 
the fluence rate only varies with z The tumour is divided 
into thin slices of thickness corresponding to a unit z 
co-ordinate (see fig 5 3) The fluence rate of excitation 
light for each of these slices is recorded and assumed 
constant for all x and y co-ordinate values of the tumour 
corresponding to each unit z value When excitation light 
strikes each slice of tumour , fluorescence is emitted in 
all directions The total yield is given by
Y - lex QE Ct (mW/cm2) (3)
where •
lex - energy fluence rate of the excitation light 
QE — quantum efficiency of HpD marked tumour slice 
Ct = concentration of HpD in tumour
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In order to simulate the fluorescent process each of 
the tumour slices is considered to be an x-y lattice of 
point sources (see fig 5 3) The emission from each of
these point sources is given off m  all directions and its
propagation back through the overlying tissue to the skin 
surface has been described by McKenzie (49) as
2Pow x (a + a ) exp - (a - a )
4( z ) - ---------5---- 5----------- -^--- !_ (mW) (4)
8ir x a x z
a
where $(z) = power at distance z from point source
Pow = Y x L (area of each unit x-y lattice)
Due to the fact that there is only a small difference in 
wavelength both for excitation and emission wavelengths the 
optical properties of tissue are considered to be 
identical From equation (4) the amount of fluorescent 
light which reaches the tissue surface from each of the 
point sources within the tumour can be obtained By summing 
the contributions from each of these point sources the 
total amount of fluorescent light which reaches the tissue 
surface from a single slice of tumour can be calculated 
Subsequently the contribution from each slice is added
1 0 2
I
In the previous section it was shown how the amount of 
HpD fluorescence which reaches the tissue surface can be 
calculated Not all of this fluorescence will be detected 
by the fibre-bundle In chapter 3 a detailed analysis of 
the collection efficiency of the fibre-bundle was 
presented Equation (4) defined the surface area of 
intersection (SA) between the excitation light cone and the 
detection light cone of the first collection fibre In this 
model equation (4) is used to calculate the intersection 
surface area (SA) at the tissue surface It is considered 
that only light which emerges from the tissue within SA 
will be sampled by the collection fibres. In fig 5 3 the 
format of the tumour-tissue structure used in this model is 
outlined For It is assumed that SA is positioned directly 
above the tumour on the tissue surface SA is divided in 
the x-y plane, into a lattice structure similar to that of 
the tumour The contribution from each point source in the 
tumour volume, to each point within the SA of intersection 
on the skin surface is then summed and a value for the 
total fluorescent light contribution within the SA, 
obtained
The fluorescent photons which emerge within the 
intersection area can be assumed to be emitted in all 
forward directions This emission is assumed constant over 
all angles from 0 to II steradians Thus the fluorescent
5 2 4 Collection Efficiency .
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power leaving the intersection area can be expressed in 
mW/steradian as
p _ total fluorescent power in intersection area
xn
The total fluorescent power collected by the first 
collection fibre can thus be expressed as
P x  n  R f 2 (mW)r = -------
k 2
where Rf *= radius of collection fibre
k = distance between SA and collection 
fibre face
There are 6 collection fibres in the inner ring of the 
fibre-bundle thus the fluorescent power sampled by the 
inner ring is 6F. In order to obtain the total fluorescent 
power sampled by the fibre-bundle F is calculated for each 
of the rings of fibres in the bundle and multiplied by the 
number of fibres in each respective ring The contributions 
from each of the rings are then summed The effects of 
oversampling by the collection fibres are ignored
The laser excitation light backscattered from the
tissue can be calculated by obtaining the value of the
backward photon flux F-(z) at the tissue surface i e at z =
0 This can be obtained from the general solution to
equations (8) (9) and (10) (see section 5 3). The value
2obtained is a light fluence rate expressed in mW/cm If 
this is multiplied by the intersection area (SA) then the 
total backscattered excitation light power leaving SA can 
be obtained The quantity of backscattered light sampled by 
the fibre-bundle can be calculated in the same way as the 
sampled fluorescent light is calculated above The detected 
fluorescence is then calculated as a percentage of detected 
backscattered excitation light and forms the basis of all 
tumour detection predictions generated by the model
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The above calculations and assumptions were 
implemented in a computer program which was developed and 
which generates predictions as to the sensitivity of the 
instrument for the detection of tumours embedded in the 
tracheo-bronchial wall. This program was written in Basic 
compiled in RiscBasic and run on an Archimedes PC with a 
Floating Point Emulator installed (see appendix 2 ) . In figs
5.5 to 5.11 typical results obtained from this program are 
presented. The graphs take the form of fluorescent : 
backscattered signal ratios (expressed as a percentage) 
plotted as a function of different parameters i.e. tumour 
dimensions , tumour depth , HpD concentration or distance 
of fibre-bundle from tissue. The dimensions of the design 
or model tumour considered in this chapter are chosen to 
represent the dimensions of early small cell carcinomas of 
the TB tract. Thus a cylindrical tumour of dimensions ; 
diameter 5 mm, thickness 0.5mm, concentration 1/xg of HpD 
per gram of tumour, embedded in healthy tissue 1.5 mm from 
the lumen of a body cavity, is assumed. The fibre-bundle is 
assumed to be positioned directly above the tumour 1 cm 
from the tissue wall. Small cell carcinomas can be present 
as a small plaque several millimetres thick or as a large 
sheet type condition thin and spread out. Figs 5.5 to 5.11
5.3 Results
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investigate the feasibility of tumour detection as the 
tumour dimensions change as the endoscope to tumour 
distance changes and as the concentration of HpD in the
tumour changes. They present an example of the predictions 
which can be obtained from this model.
One of the assumed advantages of the ratio method of 
fluorescent detection is that tumour detection is
independent of fibre-bundle to sample distance. This claim 
is investigated in fig 5.5 where the distance of the 
fibre-bundle from the TB wall (P) is plotted against signal 
ratio for the model tumour. The plot shows that signal 
ratio has a marked dependence on P In order to
investigate this anomaly fig 5.6 shows a plot of P versus 
signal ratio for two different tumour diameters. All other 
parameters are identical as in fig 5.5. It is shown that
for the larger diameter P is shown to be independent of
signal ratio.
In fig 5.7 the effect of HpD concentration on 
detection of the model tumour is investigated.
Concentrations of up to lpg of HpD per gram of tumour have 
been quoted (27) to accumulate. Fig 5.7 predicts that there 
is a linear relationship between concentration and signal 
ratio at concentrations around lpg/g. This is as expected. 
The distance between fibre-bundle and tissue wall is taken 
to be 1cm.
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One of the advantages of using red instead of violet 
excitation light is that it penetrates more deeply into 
tissue and thus can access more deeply embedded tumours In 
order to investigate how deep a tumour can be detected by 
the instrument the overlying healthy tissue thickness of 
the model tumour is increased and tissue thickness plotted 
as a function of signal ratio (fig 5.8) From fig 5 8 it is 
apparent that signal ratio decreases rapidly with tissue 
thickness up to a thickness of circa 2 5mm beyond which 
increasing tissue thickness has little effect on signal 
ratio
As has been mentioned above, early small cell 
carcinoma can present itself as a large sheet of minimal 
thickness and large diameter or as a plaque of small 
diameter and several millimetres thickness For this reason 
the cylindrical shape of the model tumour is ideal for 
assessing the feasibility of tumour detection In fig 5 9 a  
tumour plaque is simulated and the affect of increasing the 
thickness of the tumour is investigated The signal ratio 
is seen to increase linearly with tumour thickness to a 
thickness of 0 6mm after which tumour thickness becomes 
independent of signal ratio In fig 5 10 the tumour 
diameter is varied in order to simulate sheet-like small 
cell carcinoma. For small diameters increasing the tumour 
diameter has little effect on signal ratio For diameters 
above 2mm however the signal ratio increases linearly with
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increasing diameter The implications of these plots are 
that in clinical situations, if factors such as HpD 
concentration distance of bundle from tissue etc are 
known, tumour dimensions can be ascertained from detected 
signal ratios within certain limits i e for tumours with a 
diameter greater than 2 mm and thickness less than 0 6mm
In fig 5 11 the tumour diameter is varied again but 
this time as the diameter is increased the thickness of the 
tumour is decreased proportionally in order to maintain a 
constant tumour volume This plot investigates the 
feasibility of tumour detection as the model tumour gets 
longer and thinner From the plot it is apparent that when 
the tumour dimensions represent those of a plaque of small 
cell carcinoma (i e small diameter, large thickness) the 
signal ratio rises sharply with diameter As the tumour 
dimensions begin to represent sheet-like carcinoma (l e 
large diameter, negligible thickness) the signal ratio 
drops sharply and for diameters greater than 1cm the signal 
ratio is independent of diameter
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DISTANCE (cm )
Fig 5 5 Distance from sample versus signal ratio for the
model tumour.
DISTANCE (cm )
Fig 5 6 Distance from sample versus signal ratio for 
tumour surface diameters 0.5cm and 1 8cm
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CONCENTRATION (1 0 E -6 g /g )
Fig 5 7 Concentration of localised HpD 
versus signal ratio for the model tumour
TISSUE THICKNESS (m m )
Fig 5 8 Overlying healthy tissue thickness 
versus signal ratio
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TUMOUR THICKNESS (m m )
Fig 5 9 Tumour thickness versus signal ratio
TUMOUR DIAMETER (m m )
Fig 5 10 Tumour diameter versus signal ratio
112
RA
TI
O 
(P
ER
CE
NT
AG
E 
X
10
E
-2
)
4 0
30
2 0 -
10 T
/ W
\
w
\
0
0 .000  0 .500  1.000 1.500
TUMOUR DIAMETER(cm)
Fig 5 11 Tumour diameter with constant tumour volume 
plotted against signal ratio
/'
113
—  •
\j
 -^-------
2.000
One of the assumed advantages of the ratio method of
fluorescent detection is that the signal ratio is
independent of fibre-bundle to sample distance (P) (2,20) 
This assumption is shown to be erroneous in fig 5 5 Signal 
ratio is seen to fall off markedly with distance for the 
model tumour (i e tumour diameter 0 5 cm) In contrast Fig 
5.6 shows that for tumours of much larger diameter the 
assumption holds This anomaly is explained in terms of the 
collection efficiency of the fibre-bundle If the area on 
the tissue surface sampled by the collection fibres is
greater than the tumour surface area then the fibre-bundle 
will collect proportionally more backscattered excitation 
light than fluorescence This causes the signal ratio to 
drop with distance on account of the fact that the 
collection area on the tissue surface increases with P
However a tumour with a large surface area will show a 
signal ratio unaffected by variations in P This is because 
its surface area will always be bigger than the collection 
area and the same proportion of backscattered to 
fluorescent light will be detected by the fibre-bundle 
Hence the assumed distance invariance will hold
In fig 5 7 a linear plot is obtained as the 
concentration of HpD in the tumour is decreased In chapter 
3 in-vitro fluorescent detection of Hp fluorescence in 
solutions of H^O and MeOH reveal a slow tail-off of signal 
ratio at low concentrations This discrepancy is probably
5.4 Discussion
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due to the experimental difficulties involved in the 
handling of low concentrations of Hp In particular Hp has 
a tendency to stick to the sides of the cuvette causing 
experimental inaccuracy Alternately there is some evidence 
to suggest that the fluorescent quantum yield of Hp in 
solution changes with concentration On account of the lack 
of available data this phenomenon was not accounted for in 
the model and may explain the difference between 
experimental and theoretical data at low concentrations 
Aside from this anomaly, experimental (chapter 3) and 
theoretical data show very good agreement
The variation of signal ratio with the thickness of 
overlying healthy tissue is plotted in fig 5 8 In chapter 
3 it has been observed experimentally that the lowest 
signal ratio that can be detected by the endoscopic
_ 3instrument is approximatly 6 x 10 % If this criteria is
applied to fig 5 8 it can be predicted that the instrument
will detect the model tumour beneath an overlying tissue 
thickness of up to 2 4mm The implication of this in 
clinical terms is that the instrument is sensitive enough 
to detect the model tumour deep into the submucosa of the 
tracheo-bronchial tract
Fig 5 9 examines what happens when the tumour
thickness is increased The plot rises steadily but levels 
off after a thickness of 0 6mm An explanation for this may 
be because the excitation signal drops significantly inside
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the tumour and thus after 0 6mm the localised HpD is not 
stimulated to fluoresce therefore the increased tumour 
thickness does not contribute to the fluorescent signal If 
6 x 10 % is taken as the lowest signal ratio that can be 
detected by the system then from fig 5 9 it is apparent 
that model tumours with thicknesses less than 0 3mm will 
not be detected
Variation of the tumour diameter in fig 5 10 shows 
very little change in signal ratio for small diameters As
the diameter increases to the point where the tumour
I
surface area approaches that of the collection surface area
on the tissue surface, the signal ratio increases
significantly The signal ratio is expected to reach a
saturation level beyond which increasing the tumour
diameter will have no effect on the signal ratio A signal 
“3ratio of 6 x 10 % corresponds to a tumour diameter of 
circa 2 5mm in fig 5 10 The implication of this is that 
small cell model tumour plaques with diameters less than 
2 5mm will go undetected by the system However such 
tumours are very small in size (i e diameter = 2 5mm and 
thickness = 0 5mm) and could be considered to be in a very 
early stage of development and in no danger of becoming 
invasive i.e spreading to other parts of the body
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In fig 5 11 the diameter is varied but the tumour 
volume is kept constant Thus as the diameter is increased 
the thickness is decreased in order to maintain the volume. 
This plot gives us an indication of the system's detection 
limit for small and spread out sheet-type tumours In fig 
5 11 the signal ratio rises initially as the tumour 
diameter approaches that of the detection overlap area 
This is because the energy fluence rates at the deeper 
levels of the tumour are very low and these levels do not 
contribute significantly to the fluorescent process As 
these deeper levels are cut away the tumour becomes longer 
and thinner and eventually the levels with significant 
energy fluence rates are disregarded causing the signal to 
drop sharply All points on the plot are above the 6 x
- 310 % limit of detection This implies that all model 
tumours with a thickness of 0 5mm will be detected 
irrespective of their diameter and that thickness is the 
deciding factor in terms of whether the tumour will be 
detected or not
A theoretical analysis of the clinical behaviour of 
our instrument has been presented in this chapter A 
mathematical model which incorporates fibre-geometry, 
light-tissue interaction, tumour fluorescence and 
collection efficiency considerations, has been developed 
This model is then incorporated in a computer program which 
then serves to generate predictions as to the performance 
of the instrument for the detection of a model or target 
tumour The target tumour is assumed to be cylindrical in 
shape with dimensions , diameter *= 5mm , thickness - 0 5mm 
, with an overlying overlying healthy tissue thickness of 
1 5mm and a concentration of lpg of HpD per gram of tumour 
This model or target tumour mirrors the dimensions of early 
small cell carcinomas of the tracheo-bronchial (TB) and 
gastro-intestinal (GI) tracts The model can be easily 
adapted to describe other systems with, maybe a different 
excitation wavelength and source or a different fluorescent 
detection technique
The model predictions presented in this chapter do not 
constitute a full analysis of the clinical performance of 
the instrument They rather provide an indication of the 
kind of data that can be obtained from the model In 
clinical procedures the model should play a role in tandem 
with the sensitivity analysis carried out on the instrument 
in chapter 3 Such a comparison could be used to plan light 
doses and determine whether detection is feasible in a
5 5 Conclusion
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given situation.
The model predictions are presented in figs 5 5 to 
5 11 From fig 5.5 it is seen that tumour detection is not 
independent of fibre-bundle to tissue distance for the 
target tumour, as assumed by the ratio method of 
fluorescent detection In fig 5 6 however independence is 
found for tumours of larger diameter This anomaly is 
explained in terms of the geometry of the 
fibre-bundle In clinical situations the dimensions of the 
tumour will not be known and thus endoscope to tissue 
signal ratio invariance cannot be assumed as an advantage 
of the ratio method
From the sensitivity analysis carried out on the 
system in chapter 3 we know that the smallest signal ratio 
detectable by the system is 6 x 10 3% This criteria is 
applied to the model results in order to ascertain the 
limits of tumour detection From fig 5 8 it is apparent 
that model tumour detection can occur below a maximum 
healthy tissue thickness of 2 4mm The extent of epithelial 
tissue (where small cell carcinomas originate) in the TB
and GI tracts is approximately 1.5-2 0mm Thus the system
(
is sensitive enough to detect the model tumour throughout 
the extent of the epithelial layer
From fig 5 9 the model predicts a minimum detectable 
model tumour thickness of 0 3mm As the diameter of the
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model tumour is 5mm the minimum cylindrical tumour volume 
’ *
3that can be detected is thus 5 8 mm . This represents the 
minimum volume of sheet-like small cell tumour that can be 
detected In fig 5 10 a minimum detectable diameter of 2 5 
mm is predicted for the model tumour (i e thickness = 
0 5mm) This results in a minimum detectable volume of 2 4
3mm for a plaque-like small cell tumour. These predictions 
indicate that the system can detect small cell carcinomas 
while still contained in the epithelial layer. X-ray and 
nuclear medicine techniques quote a tumour detection
3resolution of 1cm at which point the tumour has either 
invaded the lumen of the body-cavity or become invasive 
(i e entered the sub-mucosa and possibly the bloodstream) 
Thus the system outlined in this project may prove valuable 
in screening sections of the population known to be at high 
risk for the development of small cell carcinomas
The model predictions in this chapter are observed to 
be of the same order of magnitude as the concentration 
curves obtained for the system m  chapter 3. This is 
encouraging but the accuracy of the model's predictions can 
not be fully assessed until they are compared with clinical 
experimental results. At present there is no clinical 
application of fluorescence endoscopy or photodynamic 
therapy in this country In the absence of any such 
clinical trial results experiments are carried out on a 
tissue-tumour phantom in chapter 6 and the results obtained 
compared with those of the model
Chapter 6
EXPERIMENTS ON A TISSUE-TUMOUR PHANTOM
In chapter 3 an instrument for tumour detection using 
fluorescence endoscopy was described Several experiments 
on the in-vitro detection of Hp fluorescence were then 
conducted, and it was found that the instrument was 
capable of detecting fluorescence from low concentrations 
of Hp in solution In vitro samples can be expected to 
have different optical properties from m  vivo samples 
For this reason, in chapter 5 the instrument was modelled 
for the in vivo detection of small cell carcinomas of the 
tracheo-bronchial tract In order to investigate the 
accuracy of the model's predictions a tumour-tissue 
phantom with readily tunable optical properties was 
developed The phantom was constructed in order to 
approximate as near as possible the dimensions of the 
model tumour investigated in chapter 5 In this chapter 
the design of the phantom is described Experiments are 
carried out on this phantom and the response of the system 
to variations in
(1) Hp concentration
(2) fibre-bundle to phantom distance
(3) overlying tissue thickness
are compared with the results obtained in the model
6 1 Introduction
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The use of phantoms for dose estimation and therapy 
planning is well established in the fields of radiotherapy 
and diagnostic imaging. Very little work has been done on 
the development of realistic tissue phantoms m  
photomedicine Such phantoms would allow the testing of 
models of light propagation and the determination of light 
flux distributions for various treatment techniques In the 
related fields of PDT and fluorescence endoscopy such 
phantoms would amongst others permit the investigation of 
such questions as the effect of photosensitiser 
concentration on fluorescent yield Wilson and Patterson 
(48) have suggested the following four criteria for the 
ideal tissue phantom
(1) the ability to simulate optical properties of a 
range of tissue types
(2) the ability to offer stable and reproducible
1
optical properties
(3) the ability to have selectable geometry
(4) the capability of incorporating tissue boundaries 
and interfaces
6 2 Theory
There are currently two schools of thought relating to 
the development of tissue phantoms in light dosimetry One 
school advocates the use of actual excised human or animal 
tissue as the phantom material (52) While this approach 
has the advantage of realism a number of problems arise in 
the handling of such tissue Firstly it has been shown that 
the optical properties of this post-mortem tissue can be 
radically different from those of living tissue due to 
deoxygenation and blood drainage (50) Secondly the 
properties of excised tissue change with time causing 
irreproducible results (52)
The second school advocates the use of inert materials 
to replicate the properties of tissue in vivo In order to 
fabricate "tissue" in this way account must be taken of the 
relative mixture of scattering and absorption centres 
within a specific tissue type For this reason most such 
phantoms consist of mixtures of scattering and absorbing 
materials Marynissen and Star (51) reported the design of 
a liquid phantom of polyvinyl acetate particles (pure 
scatterers) suspended in India ink ( a pure absorber) 
Similar phantoms have been described by Takatani (52) who 
used blood (absorber) and milk (scatterer) and Wilson (50) 
who choose blood and agar By varying the relative 
concentrations of these materials the optical properties of 
different tissue types could be obtained These phantoms 
have the advantage over excised tissue in that they can be 
easily tuned to simulate a wide range of tissue and that 
the optical properties obtained are reproducible Moes et
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al (47) have recently used a mixture of the dye Evans Blue 
(absorber) and a 10% Intralipid solution (scatterer) as a 
phantom medium for the investigation of energy fluence 
rates at 633nm This mixture forms the basis for the tissue 
phantom described in this chapter This solution was chosen
t
partly because the materials were readily available and 
partly because an accurate account of the relationship 
between optical properties and the relative concentrations 
of scatterer and absorber is available in the literature
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The m a m  aim of this chapter is to check the accuracy 
of the mathematical model as described in chapter 5 For 
this reason it is essential that the tissue phantom will 
have the same optical properties as those assumed in 
chapter 5 Thus the phantom must have the following 
properties .
Scattering coefficient a = 7 9 cm 1
S
Absorption coefficient a = 0 4 cm 1
a
Anisotropy factor g = 0 71
The tissue phantom described by Moes et al (47) consists of 
a mixture of Evans Blue and Intralipid Moes carried out a 
series of absorption and scattering measurements and was 
able to report that with g <= 0 71 the scattering
coefficient of a 10% solution of Intralipid and water 
yields a scattering coefficient of
-3
a — 38 6 x 10 mm /ml of solution/litre of water
Similarly Evans blue, the absorbing medium, at a 
concentration of 515mg/litre of water has an absorption 
coefficient of
“3 “1a = 7 6 x 10 mm
6 3 Phantom Design
126
These two substances were then mixed accordingly in 
order to obtain a tissue simulating phantom with
/
( 7 = 0  4cm 1, a = 7 9cm 1 and g = 0 71a s
In order to simulate a HpD marked tumour embedded in 
healthy tissue a "phantom tumour" is introduced into the 
tissue simulating phantom The "phantom tumour” consists of 
a solution of Hp + H^O. By means of a specially designed 
container the tissue and tumour phantoms can be positioned 
to simulate a HpD marked tumour with over and underlying 
layers of healthy tissue
A schematic view of the phantom container is presented 
in fig 6 1 and its construction is described below
A cylindrical shaft 4 5cm in depth and with a diameter 
of 0 8cm was drilled in a 5 x 5 x 4cm perspex block A 
similar 0 8cm diameter hole was drilled in a number of 
0 5mm thick glass slides The sides of the perspex block 
were painted matt black The shaft in the perspex block can 
be filled with the tissue phantom in order to simulate a 
thick slice of tissue Similarly the tissue or tumour 
phantoms can be placed in the centre of the glass slides 
The liquid phantom material is enclosed within the slides 
by means of microscope cover slips It was assumed that the 
thickness of the microscope cover-slips did not affect
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light propagation within the phantom This container allows 
the position of the tumour phantom to be varied within the 
layers of tissue phantom
6.4 Experiments
In this chapter the response of the fluorescent
detection system, described in chapter 3, is measured using 
the tissue-tumour phantom Several experiments were carried 
out and the results obtained are compared with those 
obtained from the clinical model outlined in chapter 5 In 
this way an indication of the accuracy of the model's
predictions can be obtained
In all three sets of experiments were carried out. 
Firstly the sensitivity limit of the system is determined 
and compared with that obtained in chapter 3 for the 
in-vitro detection of Hp fluorescence from a cuvette
containing a solution of Hp + H^. Secondly the
relationship of fibre-bundle to sample distance is 
investigated and compared with the model predictions
Finally the relationship between overlying healthy tissue 
thickness and signal ratio is investigated by varying the 
depth of the tumour phantom within the tissue phantom and 
recording the signal ratio. The resultant plot is again 
compared with that generated by the clinical model. The 
experimental procedures carried out in these three sets of 
experiments are outlined below
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The sensitivity limit of the instrument for detection 
of fluorescence from the phantom was determined by filling 
the shaft of the perspex block with the tissue simulating 
substance and covering the shaft with a microscope cover 
slip A drop of Hp solution was placed in the centre of one 
of the glass slices and enclosed front and back by a cover 
slip Fluorescent detection was via the ratio method and 
the signal ratio was measured for successively more dilute 
solutions of Hp + H20 . A plot of signal ratio versus
concentration of Hp in solution was obtained and the lowest 
concentration of Hp for which fluorescence could be 
detected (i e the sensitivity limit) was measured.
The perspex block was again filled with the tissue 
simulating phantom and the tumour phantom (consisting of a 
glass slice containing lpg/ml of Hp + MeOH) was placed on 
top of the block The distance of the fibre-bundle from the 
phantom was then increased in steps of 0 5cm and the signal 
ratio measured for each step A plot of distance from 
phantom versus signal ratio was thus obtained
In this experiment a glass slip containing 1/xg/ml of 
Hp + MeOH was placed on top of the perspex block 
(containing the tissue simulating material). The glass slip 
was considered to represent a HpD marked tumour. Slips of
6 4.1 Procedure
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0.5mm thickness containing the tissue simulating material 
were then successively placed on top of the "tumour" and 
the signal ratio noted as a function of overlying tissue 
thickness. A plot of signal ratio versus thickness of 
overlying "tissue" was thus obtained. This plot could be 
directly compared to that generated by the clinical model 
(chapter 5) in order to assess the accuracy of the model's 
predictions.
6.5 Results
In figs 6.2 - 6.4 representative results obtained from 
some of these experiments are plotted. In fig 6.2 a plot of 
signal ratio versus concentration of Hp in H^O is 
presented. The plot falls sharply with concentration for 
concentrations greater than 10 pg/ml. Below lOpg/ml the 
plot begins to tail off yielding a lowest detectable 
concentration of Hp (i.e the sensitivity limit ) of circa
0.7pg/ml. For each of the points displayed on the plot four 
measurements were taken and the average value recorded.
In fig. 6.3 the signal ratio is plotted against 
distance of fibre-bundle from sample for both the results 
obtained from the phantom experiments (square points) and 
those obtained from the model predictions (circular 
points). The experimental phantom points all represent the 
average of three separate measurements and error bars are 
included for accuracy. When the experimental error bars
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are included the plots show good agreement underlining the 
fact that the ratio method of utilised in our system does 
not result in the previously assumed independence of 
fluorescent detection with fibre-bundle to sample 
distance
In fig 6 4 the model predictions (circular points) 
and phantom results (square points) are presented together 
for the variation of signal ratio with overlying 
healthy-tissue thickness. The phantom results are again the 
result of the average of three measurements and the 
inclusion of error bars indicates good agreement between 
the model and the experimental results Both plots show a 
rapid fall off of signal ratio with tissue thickness for 
thicknesses less than 1 5mm Increasing the tissue 
thickness above 2mm for the phantom and circa 2 5mm for the 
model has no effect on the signal ratio This is because 
the signal ratio at these thicknesses is below the noise 
level and thus no tumour detection can occur
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CONCENTRATION^ 1 0 E -6 g /m l)
Fig 6.2 Concentration of Hp in H^O versus signal ratio for
the tumour phantom.
DISTANCE FROM SAMPLE (cm )
Fig 6.3 Distance of fibre-bundle from sample plotted 
against signal ratio for both phantom (square points) and 
model (circular points) results.
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Fig 6 4 Healthy tissue depth plotted against signal 
ratio for both phantom (square points) and model (circular
points) results.
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From fig 6 2 it is found that the sensitivity limit
for the detection of Hp fluorescence from the tissue-tumour
phantom using the detection system described in chapter 3
is circa 0 . 7 fig of Hp per ml of H20 A similar experiment
carried out on a solution of Hp and methanol (MeOH) yielded
a sensitivity limit of just under 0 lpg/ml. These
concentration sensitivity limits for the detection of Hp
fluorescence are a factor of 10 less than those obtained in
chapter 3 This is to be expected as in chapter 3
fluorescence is detected from Hp solutions contained in a 1
cm thick cuvette. This results in an excited volume of
3solution of 0 35 cm The total tumour phantom volume (i e 
the glass slip containing the Hp solution ) is 0.08 cm 
Thus the greater excited volume in chapter 3 would be 
expected to produce the most fluorescence
The dimensions of the tumour phantom were chosen to 
approximate the dimensions of the model tumour outlined in 
chapter 5 The design of the model tumour in turn was based 
on the common dimensions of early small cell carcinomas of 
tracheo-bronchial tract Thus the sensitivity limits 
obtained with our system for the detection of fluorescence 
from the tumour phantom can be considered to approximate 
clinical sensitivity limits for the detection of HpD marked 
tumours
6 6 Discussion
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One of the assumed advantages of the ratio method of 
fluorescent detection is that detection is independent of 
variations in fibre-bundle to sample distance Model 
predictions (chapter 5) indicate that this is only true for
i
tumours of large diameters Fig 6 3 confirms this 
prediction The model and phantom results show a marked 
fall off with increasing distance The two plots are 
reasonably similar in both shape and magnitude with the 
phantom results showing a slightly higher signal ratio for 
distances greater than 1 cm This is due to the fact that 
in this experiment tissue simulating phantoms were not 
placed over the phantom tumour while in the model an 
overlying healthy tissue thickness of 1 5mm was assumed
In fig 6 4 the the effect of tumour depth on signal 
ratio is shown The plot shows good agreement between the 
experimental results and the model predictions are almost 
identical for tissue thicknesses greater than 1mm Clear 
differences in magnitude are apparent however at small 
tumour depths (i e overlying tissue thicknesses of less 
than 1 mm) The reason for this disparity is still 
unclear, but could possibly be due to limitations in the 
diffusion model at low depths (i e close to the tissue 
surface)
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In this chapter a tumour-tissue phantom was designed 
in order to measure the response of the endoscopic
instrument in simulated in vivo conditions The response of
the instrument was then compared with theoretical 
predictions from chapter 5 in order to test the accuracy of 
the mathematical model
The phantom was designed to come as close as possible
to the four criteria for the ideal tissue phantom as
outlined in 6 2 The use of a liquid phantom of Evans blue 
and Intralipid fulfilled the first two criteria i e that
the phantom should be capable of simulating the optical
properties of a range of tissues and that these properties 
were stable and reproducible The use of the perspex block 
and the multiple glass slices makes it possible to control
the geometry of the phantom Also the introduction of the
"tumour slice" at selectable positions incorporates a 
tumour-tissue interface within the phantom These features 
go some way to fulfilling the two last criteria
A concentration of 1/xg/g has been quoted as the 
concentration of HpD which has been observed to accumulate 
in tumourous tissue In this chapter a sensitivity limit 
of 0 7/tg/ml has been obtained for a cylindrical tumour 
phantom consisting of a solution of Hp + IHD of dimensions 
diameter 8mm , and thickness 0.5mm The dimensions of 
the phantom were chosen to simulate clinical conditions. 
These results indicate that He-Ne excitation can excite
6 6 Conclusion
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fluorescence from concentrations of Hp in solution ( m  
simulated clinical conditions) lower than the 
concentrations of HpD measured to have accumulated in 
tumourous tissue. This implies that the He-Ne laser could 
represent an effective and improved excitation source for 
the detection of early tumours by means of fluorescence 
endoscopy
Figs 6 3 and 6 4 indicate good agreement between model 
predictions and results obtained using the phantom 
Similarly the dependence of signal ratio on fibre-bundle to 
tissue distance was not initially expected It was however 
predicted by the model and confirmed by the phantom 
experiments This seems to demonstrate that the assumptions 
made in the model are valid and that it is an accurate 
theoretical analysis of the use of our instrument for the 
excitation and detection of fluorescence through a turbid 
material
Finally this chapter confirms the validity of the 
model developed in chapter 5 and establishes a unique and 
effective tumour-tissue phantom for use in treatment and 
therapy planning for both fluorescence endoscopy and PDT 
To my knowledge this is the first complete tumour-tissue 
phantom described
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Chapter 7
CONCLUSION
I 1 Summary and Discussion
The clinical use of fluorescence endoscopy for the 
detection of intra-cavitary cancer tumours is a quite 
recent development Early clinical trials using violet 
light excitation have disappointed researchers on account 
of the large numbers of false diagnosis obtained. The use 
of red excitation light has been proposed in order to 
alleviate some of these difficulties In this project the 
use of red He-Ne laser light (632 8nm) as excitation source 
in fluorescence endoscopy was investigated
The choice of red over violet light excitation is 
based on the facts that red light has greater penetration 
in tissue and its transmission is unaffected in the 
presence of blood Similarly the auto-fluorescence signal 
from healthy tissue is much lower at red than at violet 
wavelengths The main disadvantage of using red light is
f
that it corresponds to one of the minor excitation peaks of 
HpD In chapter 2 an analysis of the photophysical 
properties of a solution of Hp + H^O was carried out using
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a spectrofluorimeter Excitation spectra revealed that the 
excitation efficiency of Hp at 410nm is approximately 75 
times greater than that obtained at 632nm Analyses of the 
fluorescent emission spectra for 410nm excitation revealed 
the presence of 3 emission bands centred at 585, 615, and 
680nm respectively The emission spectra obtained for 
excitation at 632nm revealed a single emission band centred 
at 685nm.
Sensitivity limits i e the lowest concentration of Hp 
in solution for which fluorescence can be detected by the 
spectrofluorimeter, were obtained for both 410 and 632nm 
excitation. Comparison of these limits revealed a 
sensitivity limit for 410nm excitation 300 times lower 
than that obtained for 632nm excitation The limit for 
410nm excitation was 1 x 10 3/ig/ml while for 632nm 
excitation a limit of 0 36/ig/ml was obtained This 
demonstrates why 410nm light has been the preferred 
excitation wavelength in fluorescent endoscopy The use of 
red excitation light however offers the possibility of 
detecting bloody tumours and cancers deeply embedded in 
healthy tissue It was shown in chapter 2 that 632nm light 
can excite fluorescence in a Hp solution, with a 
sensitivity limit of 0 36pg/ml This limit is below the 
lpg/ml concentration of HpD quoted (27) to accumulate in 
tumourous areas and indicates that He-Ne laser excitation 
could be effective for the detection of remote tumours 
inaccessible to violet excitation
1
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In chapter 3 a system was designed for the detection 
of Hp fluorescence incorporating a He-Ne laser as 
excitation source. The careful choice of photomultiplier 
tube and the use of an optical chopper and lock-in 
amplifier renders the system sensitive to low level 
fluorescent signals. The use of optical filters in the 
ratio method of fluorescent detection eliminates stray 
signals from the detection process. A fibre-bundle was 
introduced into the system in order to simulate tumour 
detection using a fibre-optic endoscope. The design of the 
fibre-bundle proved of crucial importance in terms of the 
efficiency of signal collection. In experimental tests the 
system attained a lowest measurable signal ratio of 6 x
-  310 % . This corresponded to a sensitivity limit of
0.01pg/ml for solutions of Hp and Methanol and a limit of 
approximately 0.1/xg/ml for a solution of Hp + H^. The 
sensitivity limit for Hp + H^O is lower than that obtained 
in chapter 3 for 632nm excitation using the 
spectrofluorimeter. This demonstrates the effectiveness of 
the system for the detection of Hp fluorescence.
The system designed and tested in chapter 3 could 
easily form the basis of a clinical instrument for the 
performance of fluorescence endoscopy. In this regard the 
ratio method of fluorescence detection offers the solution 
to some of the problems inherent in clinical measurements
1.e. variations in surface topography and changes in 
efficiencies of exciting and detecting apparatus. However
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as shown in chapters 5 and 6 it does not solve the problem 
of the variation in signal with fibre-bundle to tissue 
distance. The solution to this problem would be of great 
benefit to the clinician.
Of the methods reviewed in chapter 4 the diffusion 
theory seems to be the best method of describing laser 
interaction with highly scattering tissue as it allows for 
the presence of a collimated light flux within the tissue. 
Other techniques have been recently mentioned in the 
literature including the discreet ordinates and
Monte-Carlo techniques. These methods are complex and 
prohibitive in terms of the computing time and power
required. The diffusion theory is used as the basis for 
the clinical model described in chapter 5. Despite several 
simplifying assumptions in particular those concerning the 
2-D grid-like structure of the tumour and the collection 
efficiency of the bundle the model generates predictions 
which are similar in magnitude to the in vitro results 
obtained in chapter 3. A target or model cylindrical 
tumour is assumed of diameter 5mm and thickness 0.5mm
positioned 1.5mm beneath the surface of the tissue. The
position and dimensions of the target tumour are chosen to 
model those of early small cell carcinoma of the 
tracheo-bronchial (TB) tract. By applying the lowest
-  3detectable signal ratio for the system (i.e. 6 x 10 %) to 
the plots generated by the model, predictions were made as 
to the size of tumour which could be detected. In this way
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the model predicts that the target tumour can be detected 
to a distance of 2 4mm below the lumen of the TB tract 
Small cell carcinomas can present as a plaque of cells or 
as a thin sheet-like condition The model predicts that 
detection will occur for sheet-like small cell tumours as 
thin as 0 3mm and for plaques with diameters as small as 
2 5mm
The model predictions obtained m  chapter 5 are 
compared with the results of tests carried out on the 
tissue-tumour phantom with the endoscopic apparatus The 
construction of the phantom and the results obtained are 
discussed in chapter 6 Reasonably good agreement is found 
between phantom and model results Tests carried but on the 
phantom confirm the model prediction that signal ratio is 
not always invariant of fibre-bundle to sample distance 
Sensitivity levels for "superficial tumours" using the 
phantom are obtained at circa 0 5pg/ml for solutions of Hp
+ H 02
The endoscopic system designed in this project has 
proven a cheap simple and effective instrument for the 
excitation and detection of Hp fluorescence It has been 
shown that fluorescence can be detected from quite low 
concentrations of Hp upon He-Ne laser excitation The 
sensitivity limit of 0 5pg/ml obtained from the phantom 
test is still below the lpg/ml quoted by Doiron as the 
concentration of HpD that localises in tumourous areas It
remains to be seen if the phantom results obtained here are 
reproducible for HpD in clinical circumstances Similarly 
the accuracy of the model predictions and the "reality" of 
the phantom will not be determined until rigorous clinical 
testing of this type of endoscopic apparatus is undertaken 
The ratio method of fluorescent detection seems to have 
eliminated some of the clinical difficulties of performing 
fluorescence endoscopy. The most troublesome problem for 
the clinician i.e the variation of fluorescent signal with 
endoscope to tissue distance, remains unresolved. It is 
hoped that further investigation will eliminate this 
problem
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The work carried out in this project is intended as an 
initial assessment of the use of He-Ne light for the
detection of small tumours via fluorescence endoscopy Much 
further investigation is required before this technique 
becomes a viable clinical tool
From a design- point of view attention should be
focused on improving the collection efficiency of the
fibre-bundle This may be achieved by increasing the number 
of collection fibres within the bundle The limiting factor 
in this regard is the ease with which the bundle can be 
manipulated within the endoscope Further research could 
also consider the addition of a small collecting lens to 
the bundle tip
The theoretical description of the instrument's 
performance, outlined m  chapter 5, utilises the diffusion 
approximation for the description of light-tissue 
interaction While the results obtained from this model 
seem quite realistic other authors have shown it to be
inaccurate at tissue interfaces and at local 
inhomogeneities This may cause serious inaccuracies m
calculating the fluence rate at the tumour-tissue boundary 
For this reason other models of light-tissue interaction 
should be investigated Monte-Carlo simulation and the 
discreet ordinate method are possibilities as they allow 
for sudden changes m  the scattering profile These models
1 2 Future Research and Development
1 4 4
may prove too complex however and a modified version of the 
diffusion approximation may be sufficient
-\
The tumour-tissue phantom provides a quick and simple 
way of testing the efficiency of the instrument Ultimately 
the accuracy of the results obtained from the phantom 
depend on how closely it simulates biological tissue Very 
little work has been reported on the design of tissue 
phantoms for use in photomedicine Further research should 
be concentrated on the incorporation of local 
irregularities within the phantom and in the closer 
investigation of the in-vivo properties of tissue Results 
obtained from any future improved phantom should be 
compared with the predictions of a theoretical model 
(either the model outlined in chapter 5 or perhaps a more 
accurate model) The phantom should be developed to the 
point where model and phantom results coincide. The phantom 
could then be used in confidence to calibrate the 
instrument and predict its accuracy prior to clinical 
procedures Such a "realistic" phantom would also find many 
other applications in the field of photomedicine
The problem of signal ratio variation with bundle to 
tissue distance is one that must be resolved if 
fluorescence endoscopy is to become a viable clinical 
procedure For tumours with a surface area smaller than the 
surface area of intersection between the excitation and 
first collection fibres the ratio is seen to drop off with
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distance This is due to increased detection of 
backscattered light This problem might be solved by using 
the excitation light reflected off the tissue surface as a 
reference This reflected signal should fall off with 
distance. If an accurate value for the refractive index of 
the tissue was known, detection of this signal would give 
the distance between the bundle and the tissue (P). Further 
measurements would yield whether P varied or not in each 
particular case. A scaling factor calculated from the model 
predictions could then be applied to the measurements in 
order to compensate for the fall off in detected signal 
ratio Techniques such as this should be investigated in 
order to alleviate the problem of signal ratio dependence 
on P
Finally, HpD is not the ideal photosensitiser. Its 
fluorescent emission upon He-Ne excitation is low and its 
ability to localise in tumourous tissue is erratic What 
is needed is a compound which has a strong fluorescence 
upon red light excitation and a good ability to localise. 
The development of such a compound is still under active 
investigation
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Appendix 1
In chapter 4 the three photon flux differential equations 
which form the basis of the diffusion approximation are 
outlined. These equations can be expressed as three 
simultaneous differentials as follows .
I P 0  " Yi <z) " ' E yi (z) + F \ (z) + B ? (z)
d£ X z ) - Y2 ( z ) - - F y1 ( z > + E y2 <!;) - c  <z)
dFc(z)
dz - Y (2) - D y3 (z)
Let the Matrix A =
-E F B
-F E -C
0 0 -D
1
The characteristic polynomial is thus
1
-E-X
■F
0
F B
E-X C
0 -D-X
which when the determinant is considered is equal to
(-D - X) (-E - X) (E - X) + F2
-(D - X) X2 - (E2 - F2)
2 „ 2*These equations yield the three eigenvalues - D, +/- (E -F )
Considering the eigenspace for firstly -D we get the 
equations
(-E + D ) v  + F v  + B v  = 0
1 2 3
-Fv + (E + D ) v - c v = 0
1 2 3
This yields by subtraction
vi (CD - CE - BF) + V 2(CF + BE + BD) = 0
therefore we can take
v = (CF + BE + BD) 
v2 = (CD - CE - BF)
1/2
2
This gives Cv3 = -F (CF + BE + BD) + (E + D) (BF + CE - CD) 
= - CF2 + C(E + D)(E - D)
therefore
v = e2 - F2 - D2
3
This yields an eigen vector for eigen value - D of
CF + BE + BD
BF + CE CD
D2 - F2
2 2 1/2In the same way for the eigen value of +(E - F ) an
eigen vector of
F
E + (E2 - F2)
0
1/2
2 2 1/ 2is obtained, and the eigen value of - (E - F ) yields
the eigen vector of
F
E - (E2 - F2)1'2
0
3
The general solution of the three simultaneous equations is 
thus
Yi (z)
i - l  , 3
ae - Dz
CF +  B ( E  +  D )  
BF  +  C ( E  -  D )  
E 2 -  D 2 -  F 2
+  /3e
2 2 1/2 
z ( E  -  F  )
E +  ( E 2 -  F 2 ) 1 /2
2 2 1/2 
- z ( E  -  F  }+ ye
E -  ( E  
0
f 2 ) 1 /2
where
C =  f  ( 2  - 3 g )
B -  7T  (2 + 3§)
D = CTa +  0's
E =  [ 2 o a  +  3 / 4 ( a a  +  ( l - g ) a s )  - a a  ]
F  =  [ 3 / 4  (<7a +  ( l - g ) < 7 s )  -CTa)]
Also let
G =  C F  +  B ( E  +  D )  
H =  B F  +  C ( E  -  D )
4
I = E2 - D2- F2 
J - E + (E2- F2)172 
K = E - (E2- F2)1'2 
L - (E2- F2)1'2
Thus the three photon flux equations can be reduced to 
three simultaneous and expressed as
F+(z) = ae"Dz(G) + j9eLz(F) + 7e"Lz(F)
F- (z) - ae'Dz(H) + 0eLz(J) + 7 e‘Lz(K)
Fc(z) - ae"Dz(I) + 0 + 0
5
Appendix 2
10 REM A PROGRAM TO CALCULATE LIGHT INTENSITIES 
20 REM AT THE DISTAL END OF THE F/OPTIC CABLE 
45 DIM A (10)
50 INPUT "ENTER' REFRACTIVE INDEX N";N 
60 INPUT"HOW FAR ARE THE FIBRES FROM THE SAMPLE";P 
7 80 INPUT "ENTER NUMERICAL APERTURE"NA
100 SIG=(NA/N) ~2)*P I
110 R=SQR(SIG/PI) *P
120 ANG=2*DEG(ATN(R/P)) of
130 A=PI*R/'2
140 INPUT"WHAT IS THE POWER OF YOUR LIGHT SOURCE" ; POW
150 INPUT"WHAT IS THE COUPLING LIGHT EFFICIENCY" ; EFF
160 I=POW*EFF/A
170 PR. "NUMERICAL AREA INTENSITY ANGLE
180 PR." APERTURE CM2 mW/cm2 DEG
190 PR. NA ,A ,1 ,  ANG
191 A (1)= I
192 A (2 ) =NA
193 A (3 )=R
194 A(4 ) =P
200 IN."ENTER FILENAME";FILE$
210 X=OPENOUT (FILE$)
215 FOR 1=1 TO 4
216 P R .#X ,A (I)
217 N. I
240 CLOSEtO
260 END
10 REM PROGRAM TO CALCULATE THE TRANSMISSION OF LIGHT 
20 REM THROUGH TISSUE
60 DIM FPLUS(200)
70 DIM FPLUS1 (2 0 0 )
80 DIM FMINUS(2 0 0 )
90 DIM FMINUS1(2 0 0 )
100 DIM FC(200)
110 DIM A (10)
115 DIM FO(210)
130 DIM FLU (20 0 )
140 PT=0
1 4 5  FLU 1=0
146 REM **************************************************
147 REM ENTERING MODEL CONDITIONS
148 REM **************************************************  
150 PR."ENTER ( 1 ) ABS. ( 2 ) SCATT. ( 3 ) ANIS. COEFFS"
160 I N. A, S , G
170 IN."ENTER THE DEPTH OF TUMOUR IN TISSUE,(mm)" ;TD 
190 IN."ENTER THE TUMOUR THICKNESS (mm)";TT 
200 IN."QUANTUM EFFICIENCY OF HP";QE 
210 IN."EXTINCTION COEFFICIENT";EX
220 IN."CONCENTRATION OF HP IN TUMOUR";CN
221 REM **************************************************
222 REM READING EXCITATION LIGHT INTENSITY
223 REM AT TISSUE SURFACE
224 REM **************************************************
231 IN."ENTER FILENAME";FILE$
232 X=OPENIN( FILE$)
233 FOR 1=1 TO 4
234 I N. #X, A ( I )
235 N. I
1
^  ^  I  • T '  ' T *  * T  P  " t *  f *  « I  »1»  * T *  * 1 '  » 1 »  * f *  * T *  ^  ' I ' *  * T *  * T *  ^  ^  ^  ^  • t "  ' T *  +  ^  < t* ' t *  * T *  * T *  Ÿ  ^  4 *  ¥  Ÿ  * t *  • f "  Ÿ  ¥  4 *  * ï *  * t "  3JC « f *  • ( *
2 3 7  REM I N I T I A L I S I N G  VARIABLES
2 3 8  REM * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
2 4 0  Y = 2 . 3 * E X * Q E * C N * ( T T / 5 1 )
2 5 0  E = ( A + 3 / 4 * ( A + ( 1 - G ) * S ) )
2 6 0  F = ( 3 / 4 * ( A + ( 1 - G ) * S ) )
2 7 0  B = S * ( 2 + 3 * G ) / 4  
2 8 0  C = S * ( 2 - 3 * G ) / 4  
2 9 0  D=A+S
3 0 0  A l = C * F + B * ( E + D )
3 1 0  A 2 = S Q R ( E ~ 2 - F ~ 2 )
3 2 0  A 3 = B * F + C * ( E - D )
3 3 0  A4=E+A2  
3 4 0  A 5 = E -A 2  
3 5 0  A6 = ( E /' 2 - F ' ' 2 - D /' 2 )
3 6 0  A L P = A ( 1 ) / A 6  
3 7 0  X=TT+TD 
3 8 0  B 1 = - A L P * A 1 / F
3 9 0  B 2 = A L P * ( ( A 1 * A 4 / F ) * E X P ( A 2 * X ) - A 3 * E X P ( - D * X ) )
4 0 0  B 3 = E X P ( A 2 * X ) * A 4 - E X P ( - A 2 * X ) * A 5  
4 1 0  BETA=( B 2 / B 3 ) +B1  
4 2 0  G A M = - ( B 2 / B 3 )
A A  H Q  T 1 1 /  U> ^  ^  ^  ^  ^  ^  ^  ^  ^  4 f  ^  •¿f •!» ^  ^  ^  «1* ^  ^  «X» 4 ^  4 ; ^  ^  ^  ^  ^  «X» «X« ^  ^  ^  ^  ^  «X* ^  ^  ^  ^  ^  ^
A  I i b i - j P l  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  « p  ^  ^  «I» ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^
4 2 2  REM CALCULATING LIGHT FLUENCE RATE AT DEPTH
A  f t  A  IQ  T T IW  ^  4 *  ^  ^  ^  ^  ^  ^  ^  ^  ■!> 4 «  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  «X» 4 f ^  ^  «X« ^  ^  X  ^  ^  ^  aX* ^  ^  «X* ^  «X* ^  ^  ^  ^  4 *  ^  "4*
r v U i v l  ^  *»* * r  *  * r  T  l r  ^  ^  T  T  ^  ^  t * T *  *r“ T *  ^  +  T '  » p  ^  ^  ^  ^  t '  ^  ^  *1» +  ^  ^  • p  ^  ^  ^  ^  ^  ' p  ^  ^  ^  ^  %* *1* ‘v  *T* *T*
4 3 0  MODE7
4 3 1  Z = 0 . 0  
4 4 0  L=0
4 7 0  FOR 1=  1 TO 2 0 0
4 8 0  FPLUS( 1 ) =  A L P * A 1 * E X P ( - D * Z ) +BETA *F*EX P( A 2 * Z ) +GAM*F*EXP( - A 2 * Z  ) 
4 9 0  FMINUS( I )= A L P * A 3 * E X P ( - D * Z ) +BETA*EXP( A 2 * Z ) *A4+GAM*EXP( - A 2  * Z ) *A 
5 0 0  F C ( I ) = A L P * A 6 * E X P ( - D * Z )
5 1 0  FLU( I ) = 2 * ( FP L U S ( I ) +FMINUS( I ) ) ) + F C ( I )
5 6 0  Z = Z + X / 2 0 0
5 7 0  I F  Z < TD THEN GOTO 7 0 0
5 7 1  REM * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
5 7 2  REM CALCULATING THE FLUORESCENT YIELD WITHIN THE
5 7 3  REM TUMOUR AREA
5 7 4  REM * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
5 8 0  F O ( I ) = Y * F L U ( I ) / 2
7 0 0  L=L+1  
7 1 0  P . L  
7 2 0  N , I
7 3 0  REM * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
7 3 1  REM WRITING TO A DATA FIL E
7 3 2  REM * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
7 4 0  IN." ENTER F ILE N A M E $";F IL E$
7 5 0  B=OPENOUT(FILE$)
7 6 0  FOR 1 = 1 5 0  TO 2 0 0  
7 7 0  P R . # B , F O ( I )
7 8 0  N . I  
7 8 5  CLOSEiO 
1 0 5 0  END
2
1 0  REM THIS PROGRAM CALCULATES THE AMOUNT OF FLUORESCENCE 
2 0  REM FROM THE TUMOUR WHICH REACHES THE COLLECTION OVERLAP 
3 0  REM AREA ON THE T IS S U E  SURFACE
4 0  IN ."E NT ER ( l ) A B S  ( 2 )S C A T T  C O E F F S " ; A ,S  
5 0  DIM P ( 4 8 , 4 8 )
6 0  DIM A ( 4 8 , 4 8 )
7 0  DIM F 0 ( 5 5 )
7 2  C CALCULATING THE FLUORESCENCE AT ONE POINT ON THE
73  C TISSUE SURFACE FROM ALL THE POINTS IN THE GRID
7 4  C STRUCTURE OF THE TUMOUR
8 0  D=A+S
9 0  IN ."E N T ER  FILENAME"; F I L E $
1 0 0  B = O P E N I N ( F I L E $ )
1 1 0  FOR F=0 TO 50  
1 2 0  I N . # B , F 0 ( F )
1 3 0  N . F
1 8 0  IN."ENTER RADIUS OF TUMOUR"; RADI 
1 9 0  H = R A D I /4 6
2 0 0  IN."ENTER HEALTHY T I S S U E  THICKNESS";L
2 1 0  IN ."ENTER TUMOUR T H IC K "; THICK
2 2 0  FOR F=0  TO 50
2 3 0  FOR J = 0  TO 45
2 4 0  FOR 1 = 0  TO 45
2 5 0  R=SQR( ( L ~ 2 ) + (  ( I * H  ) ~ 2 )  + ( ( J * H ) ~ 2 )  )
2 6 0  P ( I , J ) = ( ( H * 4 ) * ( l E - 7 ) ) * ( I N T ( F 0 ( F ) * ( D ~ 2 ) * E X P ( - D * R ) * 1 E 7 / ( 4 * P I * A * R ) 
2 7 0  N . I  +
2 8 0  N . J  '  J
2 9 0  L=L+THICK/50
3 0 0  N . F
3 0 1  C * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
3 0 2  C SHUFFLING THE ARRAY IN ORDER TO CALCULATE THE FLUORESCENCE
3 0 3  C AT EACH POINT ON THE T ISS U E  OVERLAP AREA
3 1 0  IN ." ENTER OVERLAP SURFACE AREA"; SA 
3 2 0  S l = S A / 4 6  
3 3 0  Z = R A D I/S 1  
3 4 0  Y=0
3 5 0  FOR K=0 TO 45  
3 6 0  \X=0
3 7 0  FOR L=0 TO 45  
3 8 0  FOR 1= 0 TO Z 
3 9 0  FOR J= 0 TO Z 
4 0 0  T=A BS( J+X )
4 1 0  S = A B S ( I + Y )
/  4 2 0  A ( K , L ) = P ( S , T ) + A ( K , L )
4 3 0  N . J  
4 4 0  N . I  
4 5 0  X =X -1  
4 6 0  N . L  
4 7 0  Y=Y-1  
4 8 0  N .K
3
4 9 0  IN ." ENTER FILENAME"; FILE $  
5 0 0  B=O PEN O U T(FILE $)
5 1 0  FOR 1= 1 TO 4 5  
5 2 0  FOR J=  1 TO 4 5  
5 3 0  P R . # B , A ( I } J )
5 4 0  N . J  
5 5 0  N . I  
5 6 0  CLOSE#0 
5 7 0  END
4 0  DIM P ( 4 8 , 4 8 )
5 0  IN ."ENTER FILENAME"; FILE$  
60  X = O P E N I N ( F I L E $ )
7 0  FOR 1 = 0  TO 4 5  
8 0  FOR J = 0  TO 4 5
9 0  I N . # X , P ( I , J )
1 0 0  SIGNAL = 4 * P ( I , J ) + SIGNAL 
1 1 0  N . J  
1 2 0  N . I
1 3 0  PR ."SIGN AL I S  " ,  SIGNAL
1 4 0  END
4
Acknowledgements
I would like to thank the following people without 
whom this project would not have come to fruitition. 
Firstly my supervisor Wil van der Putten whose 
encouragement patience and enthusiasm were much appreciated. 
Secondly the staff and post-grads of the Physics Department 
D.C.U whose comradeship and good humour were an 
inspiration. In particular I would like to thank the 
following people : Colin Potter for his help m
constructing the fibre-bundle, Charles Markham and Niel 
O'Hare for use of their much sought after computing 
facilities and Jean-Paul Mosnier for his help with some of 
the calculations. Finally I would like to thank my family 
and friends for the interest and forbearance shown during 
the course of this project.
The project was partially funded by the Health 
Research Board.
